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CHAPTER 1
INTRODUCTION
Background
Diabetes
Diabetes is one of the most serious health challenges is the United States. In 2007,
the prevalence of diagnosed and undiagnosed diabetes of all ages in the United States was
reported to be 23.5 million people or 10.7% of the population. The prevalence of those
diagnosed was reported to be 19.7 million people. For those age 60 years or older, 12.2
million, or 23.1% of the population have been diagnosed with diabetes. Based on 2006
death certificate reporting, diabetes was reported as the seventh leading cause of death.
Overall, the risk of death among people with diabetes is reported to be twice that of those
without diabetes (National Institute of Diabetes and Digestive and Kidney Diseases,
2008).
The prevalence of diabetes in Michigan is estimated to be 8.5% of the female
population age 18 plus years. The prevalence, reported for both men and women,
increases with age (ages 55-64 a prevalence of 16.9% and ages 65-74 a prevalence of
22%). In 2007 the combined direct and indirect costs for diabetes in Michigan were
estimated to be $6.5 billion (Michigan Diabetes Action Plan, 2009).
Type 2 diabetes is a chronic disease that can result in serious, even life
threatening, long and short-term complications (American Diabetes Association, 2009).
Therefore, people with this disease require on-going medical care and diabetes selfmanagement education (DSME) to prevent these complications and to improve their
quality of life. The overall management goal is to attain and maintain glycemic control.
Nurse Certified Diabetes Educators are trained to provide individualized DSME. Self-
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management behavior change is the goal of DSME. Two key components of DSME are
nutrition management and exercise. Carbohydrate intake is the focus of nutrition
management as carbohydrates increase blood sugar levels. Exercise (150 minutes/week
of aerobic physical activity) is recommended as it has been shown to improve blood
glucose control, reduce cardiovascular risk factors, contribute to weight loss and improve
well-being.
Glycemic control measures how well diabetes is being managed (ADA, 2009).
The two primary techniques for assessing blood glucose are self-monitoring of blood
glucose (SMBG) and A1C measurement. SMBG provides measurement of blood glucose
for a specific point in time. The A1C test best reflects overall glycemic control and is
widely used as a guide to treat diabetes. The A1C test represents the proportion of
hemoglobin molecules that are glycosolated over a two to three month period. Research
has demonstrated that small variations in glycemic control can reduce the risk of
developing diabetes complications. The United Kingdom Prospective Study (UKPDS)
was a landmark clinical trial, demonstrating each 1% reduction in A1C was associated
with a decreased risk of 21% for death related to diabetes, myocardial infarction, or
microvascular complications (Stratton et al., 2000). Selvin and colleagues (2004) found
that a 1% increase in A1C was associated with an 18% increased risk of heart disease and
stroke.
Insomnia
Sleep is a multifaceted behavioral state that occupies approximately one-third of
the human life-span. Although perceived as a passive state, sleep is a highly active and
dynamic state. An adequate amount of quality sleep is necessary to lead a healthy and
productive life. Although chronic sleep loss is common in western societies, many people
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are unaware of the potential adverse health effects of sleep restriction (Punjabi &
Polotsky, 2005).
Although changes in sleep architecture occur as people age, slow wave sleep
remains relatively constant from age 60 to the mid 90s. There is no evidence that the need
for sleep decreases with age. Older individuals are reported to commonly complain of
disrupted sleep resulting in decreased sleep efficiency. Aging per se does not cause these
disruptions. Other factors such as chronic diseases, medications, primary sleep disorders
and changes in the circadian rhythm system are responsible for this decrease in sleep
(Sleep Research Society, 2005).
Insomnia has been found to be present in 30% of people over 65 years of age
(Perlis, Jungquist, Smith & Posner, 2006). Older women are more likely to report sleep
maintenance problems than men. Insomnia includes three sleep behaviors: (a) difficulty
getting to sleep, (b) difficulty staying asleep, or (c) waking up too early. Insomnia in the
aged is primarily that of waking during the night and unable to get back to sleep,
resulting in fragmented nonrestorative sleep. Older adults with insomnia are reported to
be more likely to have medical illnesses, physical disability, and elevated levels of
anxiety or symptoms of depression than those without insomnia complaints. Comorbid
insomnia treatment has traditionally focused on treating the medical condition with the
expectation that the insomnia will also resolve. Although this approach may resolve
symptoms of the comorbid disorder, the insomnia often does not improve (Roth, 2009).
Research has found that treating both the insomnia and the comorbid condition
concurrently often improves both the insomnia and the comorbid condition. Although
insomnia is likely to be treated by hypnotics, medications for chronic insomnia have been
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found to be less effective and produce negative side effects. Side effects include daytime
sleepiness, tolerance and rebound insomnia (Perlis, Jungquist, Smith and Posner, 2006).
Chronic insomnia is not a normal, or necessary, part of aging (Kamel and
Gammack, 2006). Disrupted sleep is reported, at times, to result in excessive daytime
sleepiness. Adverse outcomes of daytime drowsiness include increased risk of falls,
difficulty with concentration and memory, and overall decreased quality of life. Kamel
and Gammack (2006) also report that insomnia in the elderly is typically undertreated
and health care professionals underuse nonpharmacologic interventions.
In summary, chronic insomnia, particularly as identified as fragmented sleep, is
prevalent in aging females. People with type 2 diabetes have been reported to have more
fragmented sleep than the general population (Trento et al., 2008). The American
Academy of Sleep Medicine recommends that psychological and behavioral interventions
are effective and recommended in the treatment of chronic primary and comorbid
insomnia (Morgenthaler et al., 2006).
Although the metabolic relationship between insomnia and diabetes has not been
reported in the literature, the metabolic consequences of sleep deprivation and sleep
disruption on healthy individuals has been reported. Short-term sleep deprivation (four
hours/night for five nights) of healthy young males resulted in a 30% increase in insulin
resistance, in addition to an increased appetite for sweet and fatty foods (Spiegel,
Leproult and VanCauter, 1999). Sleep fragmentation across all stages of sleep has been
found to decrease insulin sensitivity and glucose effectiveness (Stamatakis & Punjabi,
2009).
The sleep and metabolism relationship has also been studied in persons with type
2 diabetes. Both poor quality of sleep and short sleep duration have been found to be
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associated with significantly worse glycemic control (Vigg, Vigg, and Vigg, 2003;
Knutson, Ryden, Mander, & VanCauter, 2006). The metabolic association among
obstructive sleep apnea (OSA) and fasting hyperglycemia, insulin resistance and type 2
diabetes has been studied with increasing frequency. Treatment with Continuous Positive
Airway Pressure (CPAP) was reported to result in a clinically significant decrease in
A1C. Although a relationship between interrupted sleep and increased insulin resistance
has been reported, no studies on the impact of insomnia treatment on type 2 diabetes
control were found in the literature (Hassaballa, Tulaimat, Herdegen & Mokhlesi, 2005).
In addition to the research on the metabolic impact of sleep, research on appetite
and exercise demonstrate a relationship between sleep and the diabetes self-care activities
of nutrition and exercise. Spiegel, Tasali, Penev and VanCarter (2004) conducted an
experimental sleep debt study on 12 healthy young men. Results indicated participants in
the sleep debt group experienced increased hunger, especially for carbohydrates and fats.
The researchers found that approximately 70% of the variance in increased hunger could
be accounted for by the grelin-to-leptin ratio. Chasens, Sereika, Weaver and Umlauf
(2007) studied the association among sleepiness, exercise, and physical function in older
adults. Daytime sleepiness of older community dwelling adults age 55-84 was found to
be associated with physical functional impairments and decreased exercise.
Safe and effective cognitive behavior therapy for insomnia (CBTI) is
recommended as the primary treatment for insomnia (Kryger, Roth & Dement,
2005;Morgenthaler, 2006). This treatment is a combination of psychological and
behavioral methods. Sleep restriction therapy and stimulus control procedures are
combined with a cognitive component designed to alter faulty beliefs and attitudes about
sleep. An educational component is focused on sleep hygiene principles and effects of
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diet, exercise, caffeine, alcohol and environmental factors. Usually conducted over a 4-8
week period of time, this intervention may be provided individually or in a group. Face to
face meetings are a critical component of the therapy. Research has reported continued
improvement in sleep behavior following the completion of the program (Kryger, Roth,
& Dement, 2005).
In summary, 7.87 % of the Michigan population has type 2 diabetes. Aging
women have a higher reported incidence of type 2 diabetes. Both the prevalence of type 2
diabetes and the prevalence of insomnia increase with age. The form of insomnia most
prevalent in aging is fragmented sleep. The goal of diabetes management is to attain and
maintain an A1C close to normal to prevent diabetes complications. Recent research
findings demonstrated that both poor sleep quality and short sleep duration were
associated with worsening glycemic control. CBTI has been recommended as the
preferred treatment for insomnia. No published studies were found that examined the
effect of cognitive-behavioral therapy on fragmented sleep and the relationship among
perceived sleep quality, type 2 diabetes control and self-care behaviors.
Study Purpose and Hypotheses
The purpose of this study was to examine the effects of participation in cognitivebehavioral therapy for insomnia on the sleep quality, quantity and severity of insomnia in
post-menopausal women with type 2 diabetes. A secondary purpose was to determine the
relationship among changes in sleep quality and quantity, metabolic control and diabetes
self-management behaviors. The hypotheses for this study are to:
H1:

Participation in cognitive-behavioral therapy for insomnia will improve
perceived sleep quality as measured by the Pittsburgh Sleep Quality Index
(PSQI) among post-menopausal females with type 2 diabetes.

7
H2:

Participation in cognitive-behavioral therapy for insomnia will improve
perceived insomnia severity as measured by the Insomnia Severity Index.

H3:

Participation in cognitive-behavioral therapy for insomnia will improve
sleep quantity as measured by the Actiwatch 2.

H4:

A relationship exists between change in perceived sleep quality as
measured by the PSQI and diabetes metabolic control as measured by
A1C among post-menopausal females with type 2 diabetes.

H5:

A relationship exists between change in perceived sleep quality as
measured by the PSQI and activity as measured by the Physical Activity
Scale among post-menopausal females with type 2 diabetes.

H6:

A relationship exists between change in perceived sleep quality as
measured by the PSQI and appetite as measured by the Visual Analog
Scale among post-menopausal females with type 2 diabetes
Study Significance for Society, Health Care, and Nursing

Diabetes is a devastating disease that has developed into a worldwide epidemic.
Whereas the prevalence of type 1 diabetes has remained stable, the incidence of type 2
diabetes is increasing by one million individuals annually. Women are diagnosed with
type 2 diabetes more often than men. In the United States, more women die each year
from diabetes than breast cancer. The Diabetes Prevention Program reported prevention,
or at minimum, a delay of type 2 diabetes occurred when activity was increased and
weight was decreased in people with pre-diabetes (Childs, Cypress & Spollett, 2005).
An association between sleep duration and the prevalence of type 2 diabetes has
been reported in the literature. Metabolic control in individuals with type 2 diabetes has
been reported to be worse when poor quality of sleep was reported. Research of improved
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sleep behaviors in those with obstructive sleep apnea has been associated with improved
metabolic control in individuals with type 2 diabetes. Metabolic control has been
determined to prevent long and short-term complications of diabetes. These
complications impair quality of life and often lead to death.
Insomnia, affecting 30% of the general aging population, is no longer perceived
as a necessary part of aging. This sleep disorder has the potential for increasing insulin
resistance, increasing appetite and impeding physical activity, resulting in impaired
metabolic control in women with type 2 diabetes. Research on interventions to improve
sleep behaviors in those experiencing insomnia and type 2 diabetes has yet to be studied.
The potential for decreased appetite, increased activity and improved metabolic control
needs to be investigated.
Cognitive Behavioral Therapy for Insomnia (CBTI) has been found to be more
effective than the use of medications in improving sleeping behaviors in those with
chronic insomnia. Although traditionally those psychologists trained in sleep medicine
have conducted Cognitive Behavioral Therapy for Insomnia, the need for clinicians from
other disciplines to be trained in this therapy has been reported because more clinicians
are needed. A limited number of studies have found nurses effective at conducting CBTI
(Epsie et al., 2007; Epsie et al., 2008). The addition of other disciplines to conduct CBTI
will enable additional people with insomnia to obtain this health care intervention. Nurses
certified as diabetes educators and also trained in CBTI are prepared to both conduct
CBTI and also assist with diabetes management for those experiencing both health issues.
Bulechek and McCloskey (1992) identified sleep promotion as a nursing
intervention. Nurses treat people with diabetes, regardless of the area of their practice.
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Nurses certified as diabetes educators have a unique responsibility both to advocate for
and educate their diabetic patients. Behavior change is the focus of diabetes education.
Nurses certified as diabetes educators and trained in CBTI have the background to
assist patients with both insomnia and type 2 diabetes to improve sleep behaviors. The
potential exists for an expanded role for nurse certified diabetes educators. Results of this
study do support this concept. This study was designed also to expand knowledge about
post-menopausal women with type 2 diabetes and insomnia, specifically the impact of
CBTI on A1C, appetite and activity.
Improved diabetic metabolic control is clinically significant. Results of this study
may support the inclusion of sleep assessment, education and management in diabetes
care throughout the health care system. Nursing science is both interdisciplinary and
collaborative it its art and its science. The body of knowledge that comprises nursing
science is accumulated, refined and extended as a result of research. The results of this
study will benefit nursing science by providing data to support evidence-based practice as
it relates to sleep and diabetes.
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CHAPTER 2
REVIEW OF LITERATURE
Introduction
Chapter 2 presents a review of the pertinent literature. The initial section of the
literature review provides a current overview of diabetes. The second section focuses on
insomnia. The relationship between sleep and diabetes is presented next. The fourth
section provides a literature review of cognitive behavioral therapy for improving sleep
among aging women with type 2 diabetes and insomnia. The chapter concludes with a
review of the Health Belief Model and how this model directed this research.
The Health Problem of Diabetes
Diabetes is a major health problem in the United States. In 2007, the prevalence
of diagnosed and undiagnosed diabetes of all ages in the United States was reported to be
23.5 million people or 10.7% of the population. The prevalence of those diagnosed is
reported to be 19.7 million people. For those age 60 years or older, 12.2 million, or
23.1% of the elderly population have been diagnosed with diabetes. Based on 2006 death
certificate reporting, diabetes was reported as the seventh leading cause of death. Overall,
the risk of death among people with diabetes is reported to be twice that of those without
diabetes (National Institute of Diabetes and Digestive and Kidney Diseases, 2008).
Complications of diabetes include heart disease, stroke, blindness, kidney disease,
nervous system disease, amputations, dental disease, and complications of pregnancy. In
2004, heart disease was noted on 68% of diabetes-related death certificates. For the same
time period, stroke was reported on 16% of diabetes-related death certificates. Diabetes is
the leading cause of new cases of blindness among adults 20 to 74 years of age. The
leading cause of kidney failure also is diabetes. About 60 to 70% of those with diabetes
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experience mild to severe forms of nervous system damage. More than 60% of the
nontraumatic lower limb amputations occur in people with diabetes. Periodontal disease
is more common in people with diabetes. Poorly controlled diabetes at differing stages of
pregnancy can result in birth defects or severe illness to mother and baby (National
Institute of Diabetes and Digestive and Kidney Diseases, 2008)
It is estimated that during 2005-2007, 648,100 persons aged 18 years or older
(8.5%) living in Michigan had been diagnosed with diabetes. The prevalence increased
with age to 21.1% of the population aged 65-74 years. Michigan’s diabetes prevalence
ranks 15th highest among all the states in the nation. As a result of their diabetes not being
managed well, many people are at increased risk for complications. Even though
improvements in diabetes care have led to decreased rates for diabetes-related
complications and mortality, the costs of diabetes care are increasing. (The Michigan
Diabetes Prevention and control Program [MDPCP], Michigan’s Diabetes Burden and
Diabetes Program – Overview 2008, 2009). In 2007, the estimated total cost for diabetes
in the United States was $174 billion. The direct medical costs were estimated to be $116
billion and the indirect costs were reported to be $58 billion (National Institute of
Diabetes and Digestive and Kidney Diseases, 2008).
Sleep and Insomnia
Sleep is a multifaceted behavioral state that occupies approximately one-third of
the human life-span. Although perceived as a passive state, sleep is a highly active and
dynamic state. An adequate amount of sleep is necessary to lead a healthy and productive
life. Although chronic sleep loss is common in western societies, many people are
unaware of the potential adverse health effects of sleep restriction (Punjabi & Polotsky,
2005).
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Increased morbidity and mortality have been reported to occur with reduced sleep
duration and sleep disturbances (Ayes et al., 2003; Kojima et al., 2000; Kripke,
Garfinkel, Wingard, Klauber, Marler, 2002; Mallon, Broman, Hetta, 2002; Nilsson,
Nilsson, Hedblad, Berglund, 2001). Ayes et al. (2003) reported that the risk of developing
coronary heart disease was increased by approximately 45% in subjects with an average
daily sleep duration of 5 hours or less.
Insomnia is the most common sleep complaint of adulthood. Occurring at all
stages of adulthood, this condition is often chronic and comorbid with other disorders,
particularly depression. Insomnia is defined as complaints of disturbed sleep in the
presence of both adequate occasion and circumstance for sleep. Insomnia is identified by
three features: (a) difficulty initiating sleep; (b) difficulty maintaining sleep; and (c)
waking up too early. One or more of these features indicates insomnia. Acute insomnia
may occur in anyone and is limited to one month duration. Chronic insomnia is defined
as 30 or more days of the previously stated symptoms. The term, secondary insomnia, has
been used when this condition is associated with another chronic condition, such as
depression. Although initially thought that management of the comorbid condition could
cure the insomnia, research has reported this not to be true (National Institutes of Health
State-of-the-Science Conference Statement, 2005).
Although fatigue generally is present with primary insomnia, daytime sleepiness
is not. Those experiencing insomnia often are not able to nap during the day, but rather
remain in a state of hyperarousal or hypervigilance. Mood disturbances, such as
irritability, are usually present. Research suggests that persistent untreated insomnia may
be a risk factor for major depression. Sleep loss associated with chronic insomnia may
lead to chronic sleep deprivation (Morin & Espie, 2004).
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The intensity of insomnia has no formal definition. Generally, clinical researchers
consider 30 or more minutes to fall asleep and/or 30 or more minutes of wakefulness
after sleep onset as abnormal sleep. Sleep duration is not decreased in all persons with
insomnia. Some extend their sleep opportunity to compensate for difficulty falling asleep
or maintaining sleep (Perlis, Jungquist, Smith, & Posner, 2005).
Insomnia in the Aging
Insomnia has been found to be present in 30% of people over 65 years of age
(Kyrger, Roth & Dement, 2005). Older women are more likely to report sleep
maintenance problems than men. Insomnia in this population also includes three sleep
behaviors: (a) difficulty getting to sleep, (b) difficulty staying asleep, or (c) waking up
too early. Insomnia in aging is primarily that of waking during the night and being unable
to get back to sleep, resulting in fragmented nonrestorative sleep. Older adults with
insomnia are reported to more likely have medical illnesses, physical disabilities, and
elevated levels of anxiety or symptoms of depression than those without insomnia
complaints. Although likely to be treated by medications, safe and effective cognitive
behavior therapies are available. These treatments are a combination of psychological and
behavioral methods (Kryger, Roth, & Dement, 2005).
Kamel and Gammack (2006) report that insomnia, is not a normal, or necessary
part of aging. Adverse outcomes of daytime drowsiness or fatigue are particularly
dangerous for the aging, include increased risk of falls, difficulty with concentration and
memory, and overall decreased quality of life. Kamel and Gammack (2006) also reported
that insomnia in the elderly is typically undertreated. In addition, the use of
nonpharmacologic interventions is underused by health care professionals. Disrupted
sleep in the elderly is often associated with chronic disease, including depression.
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Hidalgo and colleagues (2006) reported that in their sample of 424 noninstitutionalized
elderly insomnia participants, diabetes was the only chronic disease reported with
significant frequency.
Relationship between Sleep and Diabetes
Research on the relationship between sleep and diabetes has focused on sleep
duration, sleep disorders, and sleep quality (Gangwisch et al., 2007; Ayas et al., 2003;
Spiefel, Leproult and VanCauter, 1999). Sleep duration studies have been conducted to
determine metabolic changes that occur with shortened sleep. The sleep disorders
reported to be more common in type 2 diabetics are sleep apnea, restless legs syndrome,
and insomnia. Often, people experience more than one sleep disorder. Studies on sleep
quality focused on the relationship among sleep quality and the incidence of type 2
diabetes and diabetes metabolic control (Vigg, Vigg & Vigg, 2003; Cappuccio, D’Elia,
Strzzullo & Miller, 2010). In summary, regardless of the specific sleep focus, research
has reported a relationship of type 2 diabetes and sleep.
Sleep Duration
Epidemiologic studies have explored the relationship between sleep quantity and
quality and the incidence of type 2 diabetes. Cappuccio, D’Elia, Strazzullo and Miller
(2010) conducted the first systematic review and meta-analysis of 10 such studies (13
independent cohort samples, 107,756 adult male and female participants). Of the 10
studies, four were from Europe, four were from the United States and two were from
Japan. The inclusion criteria for this study were original article, prospective design and
assessment of sleep disturbances both at baseline and at least three years follow-up. The
sleep disturbances included short sleep duration (nine cohorts), long sleep duration (seven
cohorts), and difficulty initiating (six cohorts) and maintaining sleep (six cohorts). Short
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sleep was defined as equal to or less than 5 hours (3 studies), less than 6 hours (2 studies)
and less than 7 hours per night. Long sleep was defined as greater than 8 hours in two
studies and equal to or greater than 9 hours per night in four studies. The quality of each
study included in this meta-analysis was evaluated using the Downs and Black Quality
Index score system. The pooled risk and 95% CI for the quantity of sleep and disturbance
of sleep were estimated separately.
Cappuccio and colleagues (2010) concluded that sleep duration and sleep
disturbance consistently and significantly predict the risk of developing type 2 diabetes.
Short sleep duration was associated with a greater risk of developing type 2 diabetes.
Men (RR 2.07 [95% CI 1.16-3.72]) tended to have a greater effect than women (1.07
[0.90-1.28], heterogeneity test P = 0.04). Long sleep duration was also associated with a
greater risk of type 2 diabetes, > 9 h (n = 5; RR 1.38 [95% CI 1.15-1.65], P = 0.0006.
Difficulty in initiating sleep was associated with a greater risk of type 2 diabetes (n = 4;
RR 1.58 [95% CI 1.13-2.21] P = 0.0082. Difficulty in maintaining sleep was associated
with a greater risk of type 2 diabetes (n = 4; RR 1.67 [95% CI 1.30-2.14] P < 0.0001). In
summary, the risk varied from 28% in people who regularly sleep less than 5-6 hours per
night to 84% in those with difficulties maintaining sleep.
Although sleep deprivation in rodents has been known to result in death (Everson,
Bergmann, & Rechtschaffen, 1998), it was thought that sleep loss in humans resulted
only in increased sleepiness and decreased cognitive performance. Both the prevalence of
chronic sleep deprivation and sleep-disordered breathing (a secondary cause of sleep
deprivation) have increased in recent times. Research has identified negative metabolic
and endocrine alterations in both chronic sleep deprivation and obstructive sleep apnea.
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The effect of sleep debt on metabolic and endocrine functions was studied by
Spiegel, Leproult and VanCauter in 1999. Eleven healthy young men (18 to 27 years of
age) were studied for 16 consecutive nights. The first three nights (eight hours of sleep
each night) were used to collect baseline data. The following six nights of sleep were
limited to four hours each night. Twelve hours of sleep each night during the last seven
nights provided sleep-recovery. Carbohydrate metabolism and hormonal profiles were
assessed at the end of the sleep-debt and sleep recovery conditions. Carbohydrate
metabolism, thyrotropic function, activity of the hypothalamic-pituitary-adrenal axis, and
sympathovagal balance were studied. Glucose effectiveness was 30% lower in the sleepdebt condition than after sleep recovery. A decrease in the acute insulin response to
glucose is an early indicator of type 2 diabetes. The peak glucose concentrations in
response to breakfast in the sleep-debt condition of the young males were similar to that
seen in older adults whose insulin response to glucose is delayed. As a result, the blood
glucose rises before the insulin is secreted by the pancreas.
Spiegel, Tasali, Penev, and VanCauter (2004) conducted an experimental sleep
debt study on 12 healthy young men who did not smoke or take any medications. The
men participated in two studies, spaced at least six weeks apart. The two studies were
conducted in a randomized order. The first six participants had restricted time in bed (4
hours) and the second six performed the study with extended time in bed (10 hours).
Average weight did not change during the time separating the two studies. After the
second night, caloric intake was kept constant by infusing intravenous glucose. Validated
visual analogue scales for hunger and appetite for various foods were administered.
Results of this study reported stable leptin levels across the daytime period under both
conditions. The calories were provided by the constant intravenous infusion of glucose.
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The average sleep time for the men who spent 4 hours in bed was 3 hours and 53
minutes. The average sleep time for participants who spent 10 hours in bed was 9 hours
and 8 minutes. The mean ghrelin levels of those in the sleep restricted group were 28%
higher than those who spent 10 hours in bed. Results indicated participants in the sleep
debt group experienced increased hunger. The researchers found that approximately 70%
of the variance in increased hunger could be accounted for by the increase in the ghrelinto-leptin ratio. Further research is needed to identify the relationship of food intake and
weight gain during sleep restricted periods.
Sleep Quality and Metabolic Control
Research studies have reported on the relationship between glycemic control in
type 2 diabetics and duration and quality of sleep. Vigg, Vigg, and Vigg (2003) studied
220 adult subjects with type 2 diabetes. A questionnaire about history and management of
diabetes was administered and the Pittsburgh Sleep Quality Index (PSQI) was used to
assess self-rated sleep quality. A1C data was collected to report glycemic control. A
significant number of participants had reduced sleep duration. Both poor quality of sleep
and short sleep duration were associated with significantly worse glycemic control. The
authors recommended that sleep hygiene should be a part of routine diabetes care.
African Americans with type 2 diabetes (n = 161) were studied to determine if
sleep quality and duration impacted glycemic control. Sleep quality and duration were
measured by the Pittsburgh Sleep Quality Index (PSQI) and glycemic control was
assessed by A1C. Both restricted sleep duration and poor sleep quality were found to be
significant predictors of increased A1C levels. The increase in A1C for a perceived sleep
debt of three hours per night was 1.1% above the median. With a 5-point increase in
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PSQI score, the A1C level was 1.9% above the median (Knutson, Ryden, Mander, &
VanCauter, 2006).
Sleep disturbances in type 2 diabetes associated with glycemic control were
studied by Trento and colleagues (2008). An intervention sample of 47 patients and
control sample of 23 patients were studied. The intervention group (mean age of 61years)
was diagnosed with type 2 diabetes and treated with oral agents. The control group (mean
age of 58 years) was reported to be healthy individuals. Sleep was assessed using both
wrist-actigraphy for three consecutive days and self-reported questionnaires on sleep
behaviors. Sleep parameters derived from the actigraphy recordings were time in bed,
actual sleep time, sleep maintenance, sleep efficiency, sleep latency, fragmentation index,
total nocturnal activity and percentage of moving time. The fragmentation index and
moving time were significantly higher in patients with diabetes. The study reported that
patients with type 2 diabetes were found to move more in bed and have more fragmented,
less efficient sleep than healthy control subjects. The type 2 patients in this study had not
previously been diagnosed with insomnia. It was recommended that people with type 2
diabetes be assessed for obstructive sleep apnea, restless legs syndrome and insomnia.
Trento et al. (2008) concluded that patients with diabetes could experience improved
health and quality of life if they participated in treatment for their sleep disorders and
were provided education about healthy sleep behaviors.
Sleep and Diabetes Self-Care Management Behaviors
Most diabetes management occurs in the daily lives of individuals living with the
disease (McCormack et al., 2008). Therefore, over the past 30 years, people living with
diabetes have been encouraged to actively manage their disease. The goal of self
management programs has been to provide the knowledge and skills needed to
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successfully manage their metabolic control. The ultimate goal of self-management is to
prevent diabetes complications from occurring, resulting in improved quality of life and
increased longevity. Two fundamental self care behaviors are nutritional management
and exercise. Research has reported a relationship between sleep and both appetite and
exercise.
Nutritional management for diabetes focuses on maintaining healthy eating habits.
Since carbohydrates increase blood sugar levels, the intake of these foods is limited. As
obesity often is associated with type 2 diabetes, weight loss is advised. Sleep deprivation
has been found to be associated with increased appetite, particularly for carbohydrates
(Spiegel, Tasali, Penev & VanCauter, 2004). Spiegel and colleagues (2004) conducted an
experimental sleep debt study on 12 healthy young men. Results indicated that
participants in the sleep debt group experienced increased hunger, especially for
carbohydrates.
Exercise is another recommended self-management behavior for people with
diabetes. When exercising, insulin sensitivity is increased and calories are burned,
resulting in improved metabolic control. Aerobic exercise has been reported to improve
cardiovascular status. Research has shown that sleepiness is a barrier to physical exercise
(Chasens, Sereika, Weaver, & Umlauf, 2007). Chasens and colleagues (2007) studied the
association among sleepiness, exercise, and physical function in older adults. Daytime
sleepiness of older community-dwelling adults (age 55-84 years) was found to be
associated with physical functional impairments and decreased exercise. Increasing age
was not associated with decreases in exercise.
Sleep deprivation is common, not only in the United States but, also worldwide.
Research has reported an association between sleep deprivation and increased incidence
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of type 2 diabetes, increased insulin resistance, increased appetite, and decreased
exercise. Diabetes has also been reported to be associated with increased sleep
fragmentation. Insomnia, common in the aging population, results in sleep fragmentation
and sleep deprivation. In summary, an overview of the research on the relationship
between sleep and diabetes supports the need for sleep intervention studies designed to
improve sleep duration and quality in aging women with type 2 diabetes and insomnia.
Cognitive Behavioral Therapy for Insomnia
Psychological and behavioral interventions have been found to be effective in
improving the sleep duration and sleep quality for those experiencing chronic primary
insomnia, without the negative side effects of pharmacological treatment. The most
common individual therapies for chronic insomnia are sleep restriction, stimulus control,
cognitive therapy (CBTI), relaxation training and sleep hygiene. Although certain
individual therapies have been reported to improve sleep behaviors, programs that
incorporate various interventions have been found to be more effective in helping people
with insomnia. Integration of these therapies is known as cognitive behavioral therapy for
insomnia. No negative outcomes from this type of therapy have been reported in
published research (Perlis, Jungquist, Smith, & Posner, 2005). The individual therapies
that are incorporated into CBTI are discussed in detail below.
Sleep Restriction
Sleep restriction therapy is recommended for those experiencing both sleep
initiation and maintenance problems. This technique is designed to limit the time in bed
to the amount equal to the person’s average total sleep time. To accomplish this, a fixed
wake time is negotiated with the participant and the usual sleep time is determined. The
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recommendation is that the initial restriction be no less than 4.5 hours (time in bed)
(Perlis, Jungquist, Smith, & Posner, 2005).
Once the target amount of time in bed is determined, the bedtime is delayed to
later in the evening, or night, so that the time in bed equals the usual total sleep time.
Although initially, partial sleep deprivation occurs, the results are a more consolidated
sleep. As sleep efficiency increases, patients then increase the amount of time in bed.
This is accomplished by lengthening the time in bed by 15-minute increments on a
weekly basis when the sleep efficiency is 85 to 90%. Sleep efficiency is determined by
sleep diary data. Adjusting the time to bed rather than the wake time is essential to
prevent early morning awakenings and to prevent undermining the sleep behavior of
associating sleep with the bedroom/bed. Adjusting bedtime, rather than wake up time,
also takes advantage of the “curative” effects of delaying the sleep phase (Perlis,
Jungquist, Smith, & Posner, 2005).
The effectiveness of sleep restriction is thought to occur for two reasons. Sleep
restriction prevents patients from coping with insomnia by extending sleep opportunity.
Extending sleep opportunity results in sleep that is shallow and fragmented. In addition,
the initial sleep loss that is experienced with sleep restriction is thought to increase the
homeostatic pressure for sleep. As a result, shorter sleep latencies and higher sleep
efficiency occur (Perlis et al., 2005).
Stimulus Control
The American Academy of Sleep Medicine identified stimulus control therapy
(SCT) as the first-line behavioral treatment for chronic insomnia. This intervention has
been assessed extensively as a monotherapy and has been reported to be effective.
Stimulus control focuses on limiting the time and activities in the bed/bedroom. By so
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doing, the association of bed and sleep onset is strengthened. Typically four instructions
are provided to the person with insomnia: (a) lie down to go to sleep only when sleepy,
(b) avoid any bed or bedroom activity other than sleep or sexual activity, (c) if unable to
go to sleep in 15 minutes, leave the bedroom, (d) when sleepy, return to the bedroom.
Repeat instructions c and d as needed. A fixed wake time, regardless of the amount of
sleep, is to be maintained. This conditioning behavior is most effective when only one
stimulus is paired with one response. Therefore, the bed, or bedroom, is associated with
sleep. Stimulus control is reported to promote sleep and reinforce circadian entrainment.
While SCT is generally well tolerated, it is not recommended for individuals with mania,
epilepsy, or those prone to falls (Perlis, Jungquist, Smith, Posner, 2005).
Cognitive Therapy
Cognitive therapy is designed to change those unhealthy sleep expectations,
perceived causes and consequences of insomnia. This form of therapy is founded on the
assumption that negative emotions, maladaptive behaviors, and psychological disorders
are, for the most part, a result of dysfunctional cognitions. The goal of this form of
therapy is to assist individuals to view insomnia and its consequences from a more
realistic perspective. In addition, since insomnia patients commonly perceive themselves
as victims of this disorder, another goal of this therapy is to improve coping skills and
increase a sense of control (Morin & Colin, 2004).
Relaxation Training
Relaxation training is most suited for those who report an inability to relax or for
people with multiple somatic complaints. Four forms of relaxation therapy target
different physiological systems. Progressive muscle relaxation is effective in reducing
skeletal muscle tension. Diaphragmatic breathing is designed to induce breathing that is
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mechanically driven from the abdomen rather than from the thorax. This results in
respiration that is slower and deeper, resembling respiration that naturally occurs at sleep
onset. By having participants imagine, in a systematic way, that each of their extremities
feel warm, autogenic training focuses on increasing peripheral blood flow. Imagery
training focuses on selecting a relaxing image or memory. Guided imagery provides
direction for the participant in this form of relaxation therapy. Practice with these
interventions during the daytime improves the effectiveness at bedtime (Perlis, Jungquist,
Smith, & Posner, 2005).
Sleep Hygiene Education
Dr. Peter Hauri is identified as the first to use the term sleep hygiene,
approximately 20 years ago. The term is used in reference to those behaviors that
promote sleep (Morin & Espie, 2004). Typically, in a Cognitive Behavioral Therapy for
Insomnia intervention a handout of sleep hygiene recommendations is provided for
participants. These recommendations are thought to include a variety of behaviors that
may influence either sleep quality and/or quantity. Individualization of the suggested
behaviors is recommended. The typical sleep hygiene measures include the following:
(a) Get up at the same time each day, seven days a week; (b) Exercise regularly; (c) Make
sure your bedroom is comfortable and free from light and noise; (d) Make sure that your
bedroom is at a comfortable temperature during the night; (e) Eat regular meals and do
not go to bed hungry; (f) Avoid excessive liquids in the evening; (g) Reduce caffeine
intake; (h) Avoid alcohol, particularly in the evening; (i) Smoking may disturb sleep; (j)
Don’t take your problems to bed; (k) Do not try to fall asleep; (l) Put the clock under the
bed or turn it so that you cannot see it; (m) Avoid naps; (n) Sleep only as much as you
need to feel refreshed during the following day; (o) Establish a bedtime routine; (p) The
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bedroom should only be used for sleep and sex (Bulechek & McCloskey, 1992; Perlis et
al., 2005)
Appropriate Participants for Cognitive Behavioral Therapy for Insomnia
Perlis et al. (2005) recommended that individuals with specific characteristics are
appropriate for Cognitive Behavioral Therapy for Insomnia. These people are presented
in Table 1.

Table 1
Type of People Who Are Appropriate for Cognitive Behavioral Therapy for Insomnia
People who have or report:


Difficulty falling or staying asleep



One or more of the following

regularly extend their sleep opportunity to compensate for sleep loss and/or

stay in bed for protracted periods of time while awake and/or

engage in behaviors other than sleep and sex in the bedroom



Evidence of conditional arousal, e.g. the report of suddenly awake when getting into bed and/or
sleeping better when away from home (optional)



Evidence of poor sleep hygiene [the engagement of behaviors that reduce sleep propensity, e.g., use of
alcohol as a hypnotic, stimulant use at night (optional)

Note: Perlis et al., 2005, p. 22

Cognitive Behavioral Therapy Participant Early Withdrawal
Ong, Kue, and Manger (2008) conducted a study (n=528) aimed at identifying
those participant characteristics that were related to withdrawal from a seven-session
Cognitive Behavioral Therapy for Insomnia intervention. Their study findings indicated
that short sleep duration and elevated symptoms of depression at baseline was associated
with an increased risk of early termination.
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Providers of Cognitive Behavioral Therapy for Insomnia
Traditionally, Cognitive Behavioral Therapy for Insomnia (CBTI) has been
developed and conducted by psychologists. Usually these providers have training and/or
degrees in sleep medicine. As the field of sleep has matured providers from related
disciplines have been trained to provide CBTI. Epsie et al. (2007) conducted a
randomized clinical trial of CBTI with nurses as the therapy providers in a primary care
setting. The aim of the study was to evaluate the effectiveness of CBTI in primary care.
The two main questions were:
1. Is CBTI superior to treatment as usual in reducing chronic sleep disturbance?
2. Are there predictors of good outcome, or contradictions to the application of
Cognitive Behavior Therapy, for insomnia in general practice?
A sample of 201 adults (mean age 54 years) was recruited from 19 general
practices in Glasgow, West Lothian, and Edinburgh. Potential participants were screened
by telephone interview. A more detailed history was obtained face-to-face and
participants completed the Pittsburgh Sleep Quality Index (PSQI), the Hospital Anxiety
and Depression Scale (HADS) and the Epworth Sleepiness Scale (ESS). Participants
were randomly assigned to receive Cognitive Behavior Therapy (n=107, 72 women) or
treatment as usual (n=94, 65 women). Sleep diaries were completed for 2 weeks at
baseline, posttreatment and the six month follow-up. Objective sleep data were obtained
via actigraphy 14 nights before and after treatment.
The CBTI program consisted of 5 weekly, one hour treatment sessions. The group
size was 4 to 6 participants. The intervention included stimulus control, sleep restriction
and cognitive therapy strategies.
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Seven health visitors were trained to provide the CBTI. In the United Kingdom,
health visitors are community nurses with postqualification training and certification.
Usually they are based in primary care. The nurse therapists were provided a 12 hour, 2day course on sleep disorders, working with groups, Cognitive Behavior Therapy
principles and instruction on the CBTI program. The nurse therapists were provided a
mentor/consultant who was a psychologist with training in behavioral sleep medicine.
The consultant worked with the nurse therapists but did not work directly with the study
participants.
Study results reported that those who received CBTI experienced improvements
in self-reported sleep latency, wakefulness after sleep onset and sleep efficiency. The
improvements were partly sustained at follow-up. Participants who received treatment as
usual did not improve. Actigraphically estimated sleep improved modestly after CBTI,
although no improvement was found in the treatment as usual group. The study
concluded that nurses trained in CBTI and supervised by sleep specialists can provide
CBTI effectively in the primary care setting (Espie, 2007).
Nurses were the Cognitive Behavior therapists in a second study published by
Espie and coworkers in 2008. Cancer nurses, with no prior experience or expertise in
sleep medicine were trained to provide this therapy. This randomized control study
provided CBTI for breast cancer survivors vs. treatment as usual. Four experienced
oncology nurses were trained by attending a short CBTI course, apprenticeship learning
opportunities, ongoing mentoring by an experienced clinical psychologist and evaluation
of randomly selected session audiotapes. Five groups, of 4-6 participants each, were
conducted for five consecutive weeks. Cognitive Behavior Therapy for Insomnia was
associated with mean reductions of 55 minutes of wakefulness per night. No change was
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found in the treatment as usual group. Epsie and colleagues recommended that health
care professionals without prior expertise in sleep can be trained to provide CBTI.
Cognitive Behavioral Therapy Efficacy Studies
The first review paper summarizing the evidence regarding the efficacy of
psychological and behavioral insomnia treatments was published in 1999. In 2006, Morin
and colleagues published an update of the current research (1998-2004). Both reviews
were conducted by task forces commissioned by the American Academy of Sleep
Medicine. The purpose of the 2006 paper was to update the practice parameters of
psychological and behavioral therapies for insomnia. The criteria for studies included in
this paper identified four necessary study requirements:
(a) the main sleep diagnosis was insomnia (primary or comorbid, (b) at
least one treatment condition was psychological or behavioral in content,
(c) the study design was a randomized controlled trial, a nonrandomized
group design, a clinical case series or a single subject experimental design
with a minimum of 10 subjects, (d) the dependent measure included 1 or
more of the of the following variables (as measured by daily sleep diaries,
polysomnography (PSG), or actigraphy): Sleep onset latency (SOL),
number of awakenings (NA), time awake after sleep onset (WASO), total
sleep time (TST), sleep efficiency (SE), or sleep quality (SQ). (p. 1399)
Thirty-seven studies (n=2,246) met the criteria. The findings of the task force reinforce
earlier studies that Cognitive Behavioral Therapy for Insomnia is effective and the results
are sustained over time. Although neglected in the first paper, nearly 25% of the current
studies included older adults. Findings showed that older persons responded as well as
young or middle aged adults to CBTI. Research focused on implementation into primary
care and broadening the scope of outcome measures was recommended.
Theoretical Model
The Health Belief Model was developed in the 1950s in response to the failure of
individuals to accept preventive or early screening methods for tuberculosis. Although
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these health interventions were provided free of charge or for very low cost, people chose
not to participate. Subsequently a research project was conducted to study health patterns
and health maintenance associated with this problem (Beck, 1974). As the research group
progressed with their activities, specific characteristics became evident. The earliest
components of the model indicated that for people to take action to prevent a disease,
they must believe that (a) they are personally susceptible to the disease, (b) they could
develop the disease, which could impact some component of their lives with at least
moderate severity, and (c) they should take certain actions that could be beneficial in
either preventing the disease or reducing its severity. For the individuals to take action,
they had to perceive that they could obtain greater benefits and encounter fewer barriers.
Therefore, the original four correlates of the model were labeled: (a) perceived
susceptibility, (b) perceived severity, (c) benefits of action and (d) barriers (Becker,
1974).
Perceived susceptibility was defined as the subjective perceptions regarding risks
of contracting a condition. These risks were reported to vary from denial to being in real
danger of contracting the disease. This dimension has also been explained as a belief in
the diagnosis or susceptibility to illness in general (Becker, 1974, Becker & Janz, 1985)
Perceived severity was defined as perceptions concerning either the seriousness of
developing an illness or those of not treating it. Although severity can be perceived in
terms of the medical or clinical consequence, it can also be perceived from broader
implications, including the effects of on the job, family, and social life. Rosenstock
(1985) added that both perceived susceptibility and severity were at least partially
dependent on knowledge.
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Perceived benefits were reported as those beliefs regarding the effectiveness of
actions available to reduce the disease threat. The particular course of behavior in
response to the vulnerability of the disease is dependent on this perception. Thus, unless
the health action is perceived as feasible and efficacious, a “sufficiently threatened”
individual could not be expected to accept the recommended health action (Becker &
Janz, 1985).
The fourth of the core dimensions of the Health Belief Model was that of
perceived barriers, which are negative aspects of health action that serve as barriers to
positive action. Potential barriers include inconvenience, expense, pain, and stress.
Susceptibility combined with severity provides the force to take action. Perceptions of
benefits, minus the barriers, provide the preferred path of action. The energy or force to
act, also called “cue to action” may be internal or external. Internal cues could be
symptoms or beliefs. Examples of external cues include media communication or
interpersonal interactions (Janz & Becker, 1984).
Prior to 1974, “perceived susceptibility” was the most powerful dimension of the
Health Belief Model. In post-1974 research, barriers were found to yield the highest
significance ratios. Because the Health Belief Model is based psychologically on beliefs
and attitudes, additional variables can influence health actions. One variable that fits
conceptually is self-efficacy. Bandura (as cited in Janz & Becker, 1984) initially began
the work on this concept. He defined self-efficacy as the belief that one is able to execute
the behavior needed to produce the required outcome. Stretcher, DeVellis, Becker and
Rosenstock (1986) report that self-efficacy can be enhanced, resulting in subsequent
health behavior change. Originally designed to explain why individuals decided to take
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preventive care actions, the Health Belief Model later was used to predict the use of selfcare behaviors (Becker & Janz, 1985).
The Health Belief Model has several limitations. Most research based on the
Health Belief Model incorporates components of the model, rather than the model itself.
The original model did not incorporate several other factors, such as environment or
economics, in addition to the impact of social norms and peer influences. Lastly, although
the Health Belief Model is based on beliefs, beliefs often are the result of behavior
change (Dennison, 1996).
Theory Application to Research
The Health Belief Model has been used extensively as the theoretical foundation
for both qualitative and quantitative diabetes studies. For the present study, the model is
presented for explaining the relationship between diabetes and sleep (Figure 1). The
relationship of sleep and diabetes is reciprocal. Hypoglycemia, nocturia (as a result of
hyperglycemia) and peripheral neuropathy have been known to disrupt sleep and also
decrease sleep duration. Sleep has been reported to both directly and indirectly impact
diabetes metabolic control. Sleep deprivation has been found to cause glucose intolerance
in healthy males, decrease activity levels, and increased appetite. Persons with type 2
diabetes who have poor quality sleep have been reported to have higher A1C levels,
indicating worse diabetes control. Untreated obstructive sleep apnea has also been
associated with poor metabolic control. Based on the above, therefore, sleep impacts
diabetes and diabetes impacts sleep.
Managing both sleep problems and diabetes involves the use of self-care
behaviors. The relationship between the two health conditions is reported in the literature
to be bi-directional. Benefits and barriers are present for both insomnia and diabetes,
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impacting the management of both. For this reason, data on both diabetes self-care
behaviors and sleep behaviors will be obtained and reported. Diabetes self-care behaviors
will include appetite, exercise, and blood glucose monitoring. Insomnia behaviors will
include self-reported sleep onset latency, number and duration of awakenings, total sleep
time, sleep efficiency and sleep quality. Sleep behaviors will also be documented with the
use of actigraphy.
A diagram of the Health Belief Model as it is associated with sleep and diabetes is
provided in Figure 2. Sociodemographic, situational, and environmental variables
influence perceptions of health, an awareness of the sleep/diabetes relationships, the
perceived importance of sleep and diabetes self-care management and the perceived
benefits and barriers to sleep and diabetes self-management. Perceptions of health,
awareness of the sleep/diabetes relationships, and cues about sleep and good metabolic
control impact the perceived importance of sleep and diabetes self-care management.
Perceived benefits and barriers to sleep and diabetes self-management, along with the
perceived importance of sleep and diabetes self-management are hypothesized to increase
sleep and improve metabolic control.
Figure 3 presents the theoretical framework for this study based on the Health
Belief Model. At the construct level, insomnia management entrains disordered 24 hour
circadian rhythm that regulates the 24 hour sleep-wake pattern. This sleep-wake pattern is
hypothesized to have a relationship with metabolism, activity, and nutrition. At the
conceptual level, the behavior change phase advances the daily circadian rest-activity
acrophase, resulting in a hypothesized improved perceived sleep quality. This change in
perceived sleep quality is hypothesized to be associated with the changes in blood sugar
control, physical movement, and appetite. On an empirical level, CBTI, the independent
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variable, is defined as the method of behavior change (conceptual level). The PSQI and
the ISI are the self-report index for sleep quality (conceptual level) and actigraphy and
sleep diary are the objective measure for sleep quality. A1C, the Physical Activity Scale,
and the Analog Appetite Scale are empirical measures that evaluate concepts of blood
glucose control, physical movement, and appetite.
The Health Belief Model operationalized for the Cognitive Behavioral Therapy
intervention for insomnia is presented in Figure 4. The six domains of the model are
defined. Intervention activities associated with each of these domains are then listed.
In summary, type 2 diabetes is a serious and prevalent chronic disease. The goal
of diabetes management is to prevent short and long-term complications. As a result, the
quality of life and longevity of those living with the disease is improved. Research has
found a relationship among sleep duration, sleep quality and diabetes metabolic control.
Insomnia results in decreased sleep time and poor quality of sleep. Cognitive behavioral
therapy is a safe and effective method for treating insomnia. The Health Belief Model
was used for this study as it has a long history of use in diabetes studies and is also
congruent with the principals of CBTI. The literature has reported the need for
intervention studies to evaluate the relationship of improved sleep behaviors and diabetes
metabolic control.

Sleep
Management

Health Beliefs
Model

Diabetes
Management

Figure 1: Reciprocal Model of Sleep and Diabetes Management with Health Beliefs
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Perceptions of
health

Awareness of
sleep/diabetes
relationships

Sociodemographic,
situational, and
environmental
variables

Perceived benefits
and barriers to sleep
and diabetes selfmanagement

Perceived
importance of sleep
and diabetes selfcare management

Increased sleep
Improved diabetic
control

Cues about sleep
and good metabolic
control

Figure 2: Health Belief Model for Sleep and Diabetes Self-Management

Figure 3: Theoretical framework for the Study Intervention
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Concept

Conceptualization Definition

Operational Definition

Perceived
Susceptibility

One’s opinion of chances of getting a
condition.

1. Sleep History Assessment: How does
your night’s sleep affect your day?

Perceived
Severity

One’s opinion of how serious a
condition and its consequences are

1. Insomnia Severity Index.
2. The Sleep Behavior Self-Rating Scale.
3. Sleep History Assessment: How do you
feel about the quality of your sleep?

Perceived
Benefits

One’s belief in the efficacy of the
advised action to reduce risk or
seriousness of impact.

1. Motivation for Change Index: If there
were a treatment that would, as of
tomorrow, fix your insomnia, how would
your life be better?

Perceived
Barriers

One’s opinion of the
tangible and psychological
costs of the advised action.

1. Sleep History Assessment: What are some
things that prevent you from getting a
good night’s sleep?
2. Dysfunctional Beliefs and Attitudes about
Sleep Scale.
3. Sleep Environment Checklist.

Cues to Action

Strategies to activate
“readiness”.

1. Decision to participate in study.
2. Motivation for Change Index.

Self-Efficacy

Confidence in one’s ability
to take action.

1. Sleep History Assessment: Are you the
kind of person who usually copes well?
2. Weekly behavior change activities
negotiated based on the participant’s
confidence to complete the task.
3. Cognitive Behavioral Therapy
Intervention intended to improve selfefficacy regarding healthy sleep
behaviors.

Figure 4: Health Belief Model and Cognitive Behavioral Therapy for Insomnia
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CHAPTER 3
METHODOLOGY
Introduction
Beginning with the research design, Chapter 3 presents the study
methodology. A description of the study sample is followed by an explanation of the
study variables as they relate to the theoretical framework designed specifically for this
study. Data collection and analysis are next presented. The chapter concludes with the
study assumptions, limitations and statistical hypotheses.
Research Design
This study was designed to be a feasibility study. A quasi-experimental repeated
measures, control by constancy, research design using a pretest, intervention, posttest,
and follow-up were employed in the study. Although the independent variable was
manipulated, a control group was not included. Each participant served as her own
control. The precision of a control by constancy repeated measures design was
determined by variation within the same subject. Limited funding did not support the use
of a large sample size and/or a control group. Participants were recruited by selfselection. This quasi-experimental design included a seven-week cognitive behavioral
insomnia intervention. The diagram for this research design is presented in Figure 5.

O1

X

O2

O3

Figure 5: Pretest/Posttest Intervention with Follow-up
The Os in the figure indicate data collection periods and the X indicates the
intervention. Within two weeks prior to beginning the intervention (X), the participants
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completed the instruments for baseline data. Following the seven-week intervention (X),
the participants completed the same set of instruments a second time. Three weeks
following the completion of the intervention, the women were asked to complete the
instruments a third time. The researcher counterbalanced the instruments to help
minimize problems associated with remembering both questions and previous responses
when completing the instruments three times in an 11-week period.
Sample
The goal was to recruit 24 postmenopausal community dwelling women, aged 50
to 75 years of age, from the Metropolitan Detroit area. These women were to have been
diagnosed with type 2 diabetes for a minimum of one year and report fragmented sleep
occurring for a minimum of six months prior to entering the study.
Prior to recruiting study participants, the study was approved by the Human
Investigation Committee (HIC) of Wayne State University and Henry Ford Health
System. The study PI began recruitment of the appropriate study participants. To initiate
the recruitment process, the PI met with appropriate individuals at Metro Detroit area
diabetes educational programs, support groups, endocrinology practices, and senior
centers. Permission and support to recruit clients at each site was obtained from these
programs. Based on agreed times and dates, the investigator met with the appropriate
individual groups (educational programs and support groups) to explain the study and
recruit post-menopausal females with type 2 diabetes who met the study guidelines.
Fliers about the project were provided for possible participants who are not present at the
designated meetings.
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Inclusion Criteria
Potential study participants were female gender, 50 to 75 years of age, and
required to have self-report evidence of fragmented sleep for a minimum of six months
prior to entering the study in addition to being diagnosed with type 2 diabetes for a
minimum of one year.
Exclusion Criteria
Potential participants not meeting the criteria of fragmented sleep or being
menopausal, receiving pharmacological treatment for insomnia, being treated for any
psychiatric disorders, admitting to suicidal thoughts, a medically diagnosed sleep
disorder, or cognitively impaired were excluded. Those being treated with steroids were
also excluded from the study as these medications negatively affect both sleep and type 2
diabetes. When a potential participant was found to have an A1C greater than 9% on the
pretest session, the individual was asked to delay participation in the study until her A1C
is 9% or less. No diabetic medication dosage increases were to be made during the
intervention as this would interfere with the study results. Subjects were excluded if
diabetic medication dosages were increased.
Power Analysis
The required sample size was calculated using the Gpower computer software
(Version 3.1; Faul, Erdfelder, Lang, & Buchner, 2007). It is assumed that the correlation
coefficient of 0.50 between the variables would be considered evidence of agreement.
Based on this assumption, approximately 24 subjects are required to reject the null
hypothesis of zero correlation at the 5% level of significance with 80% power.
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Study Variables
The independent variable (CBTI) and the dependent variables (perceived severity
of insomnia, perceived quality of sleep, glycemic control, sleep quantity, physical activity
and appetite) are presented. Next, demographic, screening and confounding variables are
provided.
Independent Variable
Cognitive Behavioral Therapy for Insomnia (CBTI), was defined as a seven week
intervention designed to improve chronic fragmented sleep. (Lichstein & Morin, 2000).
This seven week CBTI intervention was designed specifically for this study. The three
treatment modalities of stimulus control, sleep restriction and sleep hygiene were
incorporated into the intervention that was provided on an individual basis.
Dependent Variables and Measurement
The major dependent variables in this study were perceived severity of insomnia,
sleep quality, sleep quantity, glycemic control, exercise and appetite. The definition of
each major study variable and the measures are presented below.
For purposes of this study, sleep quality is defined as the person’s perceived
overall sleep experience and perceived severity of insomnia. The perceived overall sleep
experience was measured using the PSQI and reported as the global PSQI score. The
perceived severity of insomnia was measured using the ISI.
The Pittsburgh Sleep Quality Index (PSQI; Buysee, Reynolds, Monk, Berman, &
Kupfer, 1989) was designed to meet four goals: (a) provide a standardized measure of
sleep quality; (b) differentiate between good and poor sleepers; (c) provide a tool that was
both easy for individuals, as well as health providers and researchers to use; and (d)
develop a useful assessment for a variety of sleep disturbances. This 19-item
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questionnaire consists of seven subscales: (a) subjective sleep quality, (b) sleep latency,
(c) sleep duration, (d) habitual sleep efficiency; (e) use of sleep medications, (f) day time
dysfunction and (g) sleep disturbance. Each subscale is rated from 0 to 3 with the higher
scores reflecting more severe sleep complaints. Analysis of the person’s overall sleep
experience is obtained by summing all subscale scores to obtain an overall score. The
lower the overall score, the better the person sleeps.
Buysee et al. (1989) reported on the reliability of the instrument. The Cronbach
alpha for the overall score on the PSQI was 0.83, which was indicative of adequate
internal consistency. The stability of the instrument was assessed using paired t-tests for
dependent samples on the seven component scores and the global score. Using a sample
of 91 patients who completed the PSQI twice at a two-week interval, no statistically
significant differences were obtained between time 1 and time 2. Statistically significant
product moment correlations were obtained between time 1 and time 2, indicating the
PSQI was considered stable over a two-week time period.
The PSQI was validated using different subject populations. Group differences
resulted in individual component and global scores. These differences were identified
using statistical testing and then validated using polysomnography
Although the PSQI provides an evaluation of overall sleep quality with adequate
reliability and validity, it is not specific to insomnia. The Insomnia Severity Index (ISI) is
a self-report instrument that measures the individual’s perception of his/her insomnia.
This seven item tool evaluates the perceived severity of sleep onset and sleep
maintenance difficulties, satisfaction with current sleep behavior, interference with daily
functioning, noticeability of impairment attributed to the sleep problem, and the degree of
distress or concern caused by the sleep problem. A scale of 0-4 is used for each item. The
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total score ranges from 0 to 28, with a higher score suggesting a more severe insomnia.
This tool has been used to both screen for insomnia and detect changes related to
insomnia treatment (Bastien, Vallieres & Morin, 2001).
Using two study samples of insomnia patients, Bastien, Vallieres, and Morin
(2001) clinically validated the internal consistency, concurrent validity and factor
structure of this self-report tool. ISI data from the first study sample (145 community
dwelling residents evaluated for insomnia at a sleep disorder clinic) was compared to the
sleep diary data of the same sample. Means and standard deviations for each of the seven
items, plus the total, were reported. The total ISI score was selected to compare with the
sleep efficiency variable of the sleep diary as the sleep efficiency is probably the best
composite measure of overall sleep disturbances. The average total score was 19.7
(SD=4.1). As computed from the sleep diary, the average sleep efficiency was 67.7%
(SD=14.55). A Cronbach alpha coefficient and item to total correlations were used to
estimate the internal consistency. Internal consistency of the ISI was 0.74. The item to
total correlations varied from a low of 0.36 to a high of 0.67. The concurrent validity was
estimated by correlating the severity rating for the subtypes of insomnia obtained from
the ISI with the corresponding quantitative estimates obtained from the sleep diaries and
the total ISI score with the sleep efficiency variable of the sleep diary. All correlation
coefficients were significant at the 0.01 probability level.
Data from the second study sample was obtained from a larger study comparing
the efficiency of cognitive behavior therapy and pharmacotherapy for late life insomnia.
The data ISI results were compared to both the sleep diary and polysomnography results.
Internal consistency of the ISI was estimated using Cronbach’s coefficient alpha and item
to total correlations at the pre, post, and follow-up evaluations. The item to total
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correlations ranged from 0.32 to 0.71, with a mean of 0.56 at pretreatment; 0.58-0.79,
with a mean of 0.69 at post-treatment; and 0.46-0.90, with a mean of 0.72 at follow-up.
The internal reliability coefficients were quite stable from 0.76 at baseline to 0.78 at
follow-up. Correlations between the change scores from the ISI with those of the sleep
diaries and polysomnography studies resulted in small but significant scores indicating
the tool is significantly sensitive to changes in insomnia. In summary, the ISI was found
to be an adequately reliable tool for assessing patient perceptions of insomnia both for
screening and intervention study purposes.
For purposes of this study, sleep quantity was defined as the duration, timing and
fragmentation of sleep and was measured by the sleep diary designed specifically for this
study and by actigraphy.
Integral to CBTI is the completion of daily sleep diaries. Sleep diaries provide
detailed self reported data needed to determine individual baseline sleeping behaviors and
needed information to conduct sleep restriction therapy. Researchers have reported that
sleep diaries provide relatively reliable information on sleep latency, wakefulness, sleep
time, and sleep efficiency (Morin & Espie, 2003). A sleep diary (See Appendix A),
specifically designed for this study, was used for self-report of sleep behaviors for
baseline data and sleep restriction therapy. Behaviors that hinder or support sleep were
documented in the diary and discussed at the weekly sessions. The assumption was made
that the study participants provide accurate data.
Although sleep diaries are traditionally used for CBTI, research has identified
variation in self-reported data on sleep diaries vs. sleep behavior data obtained via
actigraphy (Dautovich, McCrae & Rowe, 2008). Actigraphy involves the use of portable
devices that record movement over extended periods of time. These devices have been
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used extensively in the study of sleep and circadian rhythms (Morgenthaler, et al., 2007).
Although polysomnography is considered the most accurate measurement of sleep
behaviors, actigraphy is both less costly and more convenient for sleep assessment over
an extended period of time. The use of sleep diaries and wrist actigraphy provides data on
sleep behaviors as well as the subjective experience of sleep. Actigraphs are small
noninvasive instruments that record limb movement by means of an accelerometermicroprocessor link (Epsie, et al., 2006). The Actiwatch 2, by Respironics Minimmitter,
was used for this study. The Actiwatch is 43mm x 23mm x 10mm in size. With the band,
the weight is 16 grams. The recording can be measured at 15 second, 30 second, or one
minute intervals. For this study the one minute interval was used. The battery life is
dependent upon the recording frequency. The charge time for the battery is 6 hours from
empty to full. This actigraph is resistant to dust, water, heat, perspiratation and cold. The
appropriate software was used to analyze the data.
For purpose of this study, gylcemic control was defined as blood sugar regulation
and was measured by the A1C and daily blood glucose self monitoring.
The A1C test best reflects overall glycemic control and is widely used as a guide
to treat diabetes. The A1C test represents the portion of hemoglobin molecules that are
glycosolated over a two to three month period. Small variations in this blood test
represent significant differences in developing diabetic complications (Stratton et al.,
2000). The Wayne State University (WSU) College of Nursing laboratory was
responsible for analysis of this blood test.
Blood glucose self-monitoring was conducted using the Presto blood glucose
meter, by WaveSense, for a minimum of two times each day, before breakfast and before
bedtime. The Presto blood glucose meter is reported to be within a 15% range of the
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laboratory standard, 96% of the time. Most blood glucose meters are in the 20% range of
the laboratory standard. The participants maintained weekly records of their blood sugar
results. Blood glucose meter memory checks were also used.
For purposes of this study, exercise was defined as self-reported physical activity
lasting a minimum of 5 minutes as measured by the Physical Activity Scale.
The Physical Activity Scale, developed by Aadahl and Jorgensen (2003), was
used to assess self-reported physical activity in 24 hours of sports, work, and leisure time
on an average weekday. This one page tool describes nine forms of activity. The duration
of time for each category was reported for an average weekday. The total amount of time
should add up to 24 hours. Validity of this instrument was determined by comparing two
self-report measures; the Physical Activity Scale and a physical activity diary. The
“Compendium of Physical Activities” approach used for this tool is based on the concept
that the intensity of each specific activity can be expressed in metabolic equivalents
(METs). This allows for estimation of energy expenditure of specific physical activities.
The time engaged in an activity multiplied by the MET value of the activity and by body
weight results in estimated energy expenditure.
Face validity of the questionnaire was determined by interviews with 10
volunteers. Concurrent validity was explored through comparison of the activity scale
against measurement of physical activity by activity diaries and by CSA accelerometry.
The correlation between the MET-time calculated from the physical activity scale and the
average MET-time estimated from the activity diary was high (r = 0.74, P = 0.000).
Correlation between physical activity scale MET-time and average 24 hour total activity
count by accelerometry was nonsignificant (r = 0.20; See Appendix A).
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For purposes of this study, appetite was defined as the desire to eat food, or a
specific food, as reported by a study participant using a visual analog scale.
The appetite Visual Analog Scale (VAS) was used to assess hunger, satiety,
fullness, prospective food consumption, desire to eat something fatty, salty, sweet or
savory. The VAS is 100 mm in length with words anchored at each end identifying the
most positive and the most negative ratings for each of the above appetite characteristics.
Flint, Raben, Blundell and Astrup (2000) found that this widely used tool was
reproducible when used to assess appetite at a single data collection point. Validity was
difficult to determine, as an objective measure of appetite does not exist. Within-subjects
comparisons were found to be more sensitive and accurate than between-subject
comparisons. For this study, the within-subject comparison of three data collection times
demonstrated the change in the dependent variable (See Appendix A).
Demographic Variables
Demographic variables for this study included the personal characteristics of age,
education, marital status, employment, insurance and the number of people living in the
home. Data on demographic variables was collected using the investigator developed
Demographic Survey (See Appendix A).
Screening Variables
Actual sleep behaviors were verified by the use of an individual Sleep History
Guide and the Insomnia Severity Index. The Sleep History Guide (Morin & Epsie, 2004)
provided both an overview of the potential participants’ sleep background and details
regarding the current sleep problem (See Appendix A). This outline, including
appropriate prompt questions, directed the sleep behavior assessment. The Medical
History was used to guide the medical assessment (See Appendix A).
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Potential cognitive impairment was evaluated using the Mini Mental State
Examination (See Appendix A). A score of 20 or less was used to identify cognitive
impairment. The Mini-Mental State (MMS) includes eleven questions on cognitive
aspects of mental health function and required 5-10 minutes to administer (Folstein,
Folstein & McHugh, 1975). The reliability and validity testing was conducted on 206
patients with dementia syndromes, affective disorder, affective disorder with cognitive
impairment, mania, schizophrenia, personality disorders, and in 63 normal subjects.
Concurrent validity was determined by correlating the MMS scores with the Wechsler
Adult Intelligence Scale. For Mini-Mental Status vs. Verbal IQ, Pearson r was 0.776 (p <
0.0001). For MMS vs. Performance IQ, Pearson r was 0.660 (p < 0.001). The MMS was
found to have adequate reliability on 24 hour or 28 day retest by both single and multiple
examiners. When tested 24 hours apart by the same tester, the correlation by a Pearson
coefficient was 0.887. When two different examiners were used the Pearson coefficient
remained high at 0.827. When the MMS was given an average of 28 days apart, there was
no significant difference in the scores, the product moment correlation for test 1 vs. test 2
was 0.98.
Confounding Variables
Confounding variables for this study included presence of depression,
medications and daily blood glucose levels. Although the study exclusion criteria include
sleep medications, psychotropic drugs, and steroids, the list of medications that can affect
sleep is extensive (Pagel, 2005).
Although glycemic control was identified as a dependent variable, hypoglycemia
and hyperglycemia were recognized as potentially interfering with sleep quality (Childs,
Cypress & Spollett, 2005). Participants were asked to monitor daily blood sugar levels in
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the morning (fasting state) and before bedtime. Additional blood sugar testing was
conducted at the discretion of the participants. To ensure consistency of meter results,
WaveSense Presto self-monitoring supplies (blood glucose meters and strips) and
individual instruction were provided for each participant. The blood sugar readings were
recorded daily on a blood glucose report form created for this study.
Data Collection Procedure
The study was designed in four phases:
Phase 1: Pretest (recruitment, screening procedures, informed consent and
baseline data collection),
Phase 2: Seven week intervention,
Phase 3: Post-test data collection and
Phase 4: Three week follow-up.
Phase 1
Potential participants demonstrating interest in the study and meeting the initial
inclusionary requirements were contacted by telephone or in person to set an appointment
to meet with the PI. Screening for possible inclusion in the study occured over the phone
or in person using the investigator developed screening tool (See Appendix
A)specifically designed for this study. At the agreed upon time for orientation to the
study, the PI met with the participant and reviewed the informed consent form. After
obtaining written consent from the participant the PI then verified the A1C level. If the
potential participant met the inclusion criteria the PI began the data collection. A weekly
meeting time and location for the intervention was mutually determined.
The Demographic Questionnaire (See Appendix A) the Medical History (See
Appendix A), Sleep History (See Appendix A) and the Mini Mental State Examination
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(See Appendix A) directed the interview. Completion of the Medical History was used to
screen for pharmacological treatment for insomnia, treatment for psychiatric disorders
and suicidal thoughts. Assessment of steroid use and medical stability was also identified
by use of the Medical History. Participants were asked to notify the PI of any medication
changes. The Sleep History provided additional information on the sleep behaviors of the
potential study participant. The Sleep History was used to screen for potential
confounding sleep disorders. The Mini Mental State Examination was used to screen for
cognitive impairment.
Having met the inclusion criteria and following additional assessment for possible
exclusion variables, all qualified participants completed the PSQI, ISI and Physical
Activity Scale. The participant was instructed to complete the Visual Analog Scale the
following three mornings before breakfast and to return the forms at the next visit. The
mean scores of the VAS collected on three days was used for analysis at each data
collection point. An A1C test was obtained. Venous blood samples were drawn using
usual laboratory technique and stored in a vertical stopper-up position. The samples did
not remain at room temperature for more than eight hours. When the assay was not
completed in eight hours, the sample was stored at +2 degrees C to +8 degrees C
(Synchron System Chemistry Information Sheet, 2007). Assays were completed at the
WSU College of Nursing laboratory. Instruction on the use of the sleep diary, actiwatch 2
and blood glucose meter designated for this study were provided during the study
orientation. The study participant was advised to complete the daily diaries and use the
blood glucose meter during the week prior to the intervention. The participant also
received instruction on the use of the wrist actigraph. Participants were advised to wear
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the wrist actigraph on the nondominant wrist during the same seven days of data
collection.
Phase 2
Seven weekly CBTI sessions were held for each of the participants (Study
Manual, p 39). In addition to attendance at each of the sessions, participants completed
daily sleep diaries, wore wrist actigraphs and self-monitored their blood glucose, using
the WaveSense Presto meter a minimum of twice daily (fasting and at bedtime).
Individualized instructions for sleep behaviors was negotiated with each participant on a
weekly basis.
The seven-session fragmented sleep intervention was conducted individually in a
prearranged private room by the PI. Each of the seven sessions lasted from one to one
and a half hours in length. The session topics were be:
1. Introduction to treatment program, review of sleep diaries, blood glucose selfmonitoring and introduce sleep restriction;
2. Stimulus control therapy and sleep restriction;
3. Introduction to cognitive therapy;
4. Cognitive therapy and introduction to other therapies;
5. Relaxation Therapy;
6. Sleep hygiene
7. Sleep maintenance and relapse prevention; completion of the posttest
measures (Perlis, Jungquist, Smith, & Posner, 2005).
At each session the sleep diary from the previous week was reviewed to
determine the sleep goal for the coming week. The blood glucose report form was
reviewed. The actigraphs were downloaded. The questionnaire appropriate to each
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session was completed during the downloading process. The topic for each week was
presented and discussed. Additional detail for each class of the intervention is provided in
the Class Outline and Teaching Materials presented in the study manual.
Retention of participants.
As this intervention is quite demanding, potential participants were informed
about the requirements of the study prior to enrollment. Each participant was asked about
her ability to commit to the study demands. This topic was again addressed during the
first session in the Motivation for Change Index. Potential participants were expected to
attend each of the sessions. When a necessary absence occurs, a meeting was rescheduled
with the participant. When a participant was unable to complete the intervention, their
data was excluded.
Phase 3
During class seven of the intervention the posttest data was obtained. Study
participants completed the PSQI, the ISI, the Visual Analog Scales and the Activity
Scale. Since the A1C test reports change each 8 to 10 weeks, this data was collected only
during the pretest and at the follow-up session. The A1C is heavily weighted to the 2 to 4
weeks prior to collection.
Phase 4
Three weeks following the completion of the intervention the follow-up session
occurred. At this session, study participants completed the PSQI, the ISI, and the Physical
Activity Scale. A blood sample for A1C analysis was obtained and analyzed by the
Wayne State College of Nursing Laboratory. Each of the participants was asked to
complete the appetite VAS for three days before breakfast and self-monitor her blood
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sugar before breakfast and at bedtime each day prior to the follow up session. A time for
questions and discussion was provided at this meeting.
Data Analysis
SPSS – Windows, version 20.0 was used to analyze the data obtained from the
self-report tools and biomedical markers. The PI collected, coded and input the data into
a computer file, both prior to and at the conclusion of the intervention. Follow up data
was collected three weeks following the intervention. The A1C was collected prior to the
intervention and at the 3-week follow-up.
Frequency distributions and descriptive statistics were used to analyze the
demographic data to obtain a profile of the participants. The nominal and ordinal data
was analyzed using frequency distributions, while the continuous data will be analyzed
using measures of central tendency and dispersion. Data from the dependent variables of
A1C, appetite and exercise was collected as interval level data.
To address Hypotheses H1 and H2, in determining the intervention effect of
cognitive-behavioral therapy for insomnia, multivariate repeated-measures analysis of
variance and covariance was used to test the improvement in sleep quantity and quality
within and between participants. For Hypotheses H3 through H6, Pearson correlation
coefficients were utilized to determine the relationship between variables measured on
ratio or interval scales.
Assumptions
The following assumptions were made for this study:
Cognitive behavior therapy for insomnia (CBTI) has been shown to be an
effective tool in changing sleep behavior and reduces insomnia.
Participants in the study responded to surveys and maintain sleep diaries honestly.
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Participants has the capability to improve their insomnia.
Limitations
Limitations to this study included a small sample size and no comparison group.
Each subject was her own control. The study was limited to women who are between 50
and 75 years of age. As a result, the findings are generalizable to men or to men and
women who are younger or older than the targeted population. As a result of the short
study duration, long term clinical significance was not be assessed. The study was
conducted with outpatients in southeast Michigan. While results of the study may be of
interest to nursing personnel who are providing treatment for diabetes in other locations
or with people of different ages, the findings are not generalizable to their patients.
Statistical Hypotheses
H1:

Participation in cognitive-behavioral therapy for insomnia will improve
perceived sleep quality as measured by the Pittsburgh Sleep Quality Index
(PSQI) among post-menopausal females with type 2 diabetes.

H2:

Participation in cognitive-behavioral therapy for insomnia will improve
perceived insomnia severity as measured by the Insomnia Severity Index.

H3:

Participation in cognitive-behavioral therapy for insomnia will improve
sleep quantity as measured by the Actiwatch 2.

H4:

A relationship exists between change in perceived sleep quality as
measured by the PSQI and diabetes metabolic control as measured by
A1C among post-menopausal females with type 2 diabetes.

H5:

A relationship exists between change in perceived sleep quality as
measured by the PSQI and activity as measured by the Physical Activity
Scale among post-menopausal females with type 2 diabetes.
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H6:

A relationship exists between change in perceived sleep quality as
measured by the PSQI and appetite as measured by the Visual Analog
Scale among post-menopausal females with type 2 diabetes
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CHAPTER 4
RESULTS
Introduction
Chapter 4 presents the study results. The purpose of the study and the research
design are first presented. The sample description and demographics are then reported.
Following, the study results are presented according to each individual hypothesis. The
chapter concludes with additional study findings.
Purpose of the Study
The purpose of this study was twofold. First the study examined the effects of
participation in in cognitive behavioral therapy for insomnia on the sleep quality, sleep
quantity and insomnia severity in post-menopausal women with type 2 diabetes. A
secondary purpose was to determine the relationship among changes in sleep quantity and
sleep quality, metabolic control and diabetes self- management behaviors.
Research Design
The research design for this 11-week feasibility study was quasi-experimental
using a pretest, intervention, posttest, and a follow-up. Following an orientation session,
the study participants completed a seven week intervention followed by a three week
follow-up. Data was collected at baseline, week seven of the intervention and at the three
week follow-up. Figure 3, as previously presented in Chapter 2, provides the theoretical
framework for the study intervention.
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Figure 3: Theoretical framework for the Study Intervention (as previously presented)
Sample Description
The sample criteria for this study were participants aged 50 to 75 years of age
who had type 2 diabetes for a minimum of one year and insomnia for a minimum of six
months. The hemoglobin A1C level needed to be below 9% to be enrolled in the study.
Eighteen participants were consented and 16 were enrolled in the study. Seven of the 16
enrolled participants did not complete the study and were not included in the final
analysis. Two participants had elevated A1C levels above 9% and, therefore, could not be
enrolled in the study. They were unable to lower their A1C levels adequately for study
enrollment prior to the end of the study. During the study, one enrolled participant was
found to have obstructive sleep apnea and, therefore, did not meet the participant criteria.
One participant became medically unstable and also no longer met the participant criteria.
Three participants decided to drop out of the study as they reported that they needed to
focus on family issues that developed during the intervention. One participant had
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difficulty wearing the actiwatch and decided that it was not a good time for her to
participate in the study. In addition, one lady was removed from the study as she did not
follow the study protocol. A total of nine participants completed the intervention and the
follow-up. Frequency distributions were used to summarize the demographic data for the
participants and are presented in Table 2.

Table 2
Demographic Data (N = 9)
Demographic Data

Frequency

Percent*

Age
56 to 60
61 to 65
66 to 70

4
2
3

44.0
22.0
33.0

Educational Level
High school graduate
Some college
College graduate
Master’s degree

2
3
1
3

22.0
33.0
11.0
33.0

Marital Status
Single
Divorced
Married
Widowed
Separated

2
1
4
1
1

22.0
11.0
44.0
11.0
11.0

Insurance
Medicare + Private
Private

4
5

44.0
56.0

Employment
Full-time
Part-time
Retired
Disabled

1
2
5
1

11.0
22.0
56.0
11.0

*Percentages may not add up to 100% due to rounding

The age inclusion criteria for the study were women aged 50 to 75 years of age.
No participants under 56 years of age or over 69 years of age completed the study. Of
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those participants who finished the intervention and follow-up, 4 (44%) were 56 to 60
years of age; 2 (22%) were 61 to 65 years of age and 3 (33%) were 66 to 70 years of age.
Educational level as reported by participants: 2 (22%) were high school
graduates; 3 (33%) had some college; 1 (11%) was a college graduate and 3 (33%) had
Master’s Degrees. Regarding marital status, 2 (22%) were single; 1 (11%) divorced; 4
(44%) married; 1 (11%) widowed and 1 (11%) separated. Four (44%) of the study
participants reported having Medicare plus a supplemental insurance and 5 (56%) had
private insurance. Regarding employment, 1 (11%) was working full time; 2 (22%) were
working part time; 5 (56%) were retired and 1 (11%) had obtained a disability status.
Sample Characteristics
The participant’s A1C levels were tested at pretest and again at 3-week follow-up.
Their individual scores are presented in Table 3.

Table 3
Change in A1C Levels from Pretest to 3-Week Follow-up
Participant

A1C #1

A1C #2

Change

Participant A

6.9

6.5

-.4

Participant B

5.8

5.6

-.2

Participant C

7.3

6.5

-.8

Participant D

6.7

6.6

-.1

Participant E

7.9

7.8

-.1

Participant F

7.2

7.0

-.2

Participant G

8.3

7.7

-.6

Participant H

6.1

6.2

+.1

Participant I

7.0

6.9

-.1
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The A1C scores at pretest ranged from 5.8 to 8.3%, with scores at the 3-week
follow-up ranging from 5.6 to 7.8%. Eight of the nine participants in the study
experienced decreases in their A1C levels. These decreases ranged from .1 to .8%. One
woman had a 0.1% increase in her A1C score from pretest to the 3-week follow-up.
Weight was recorded at the three time periods, pretest, posttest, and 3-week
follow-up. The change in weight was tested using a repeated measures analysis of
variance (ANOVA). See Table 4.

Table 4
Weight at the Three Time Periods
Participant #

Weight #1

Weight #2

Weight #3

Overall Change

F Ratio

Sig

Participant A

165

167

165

0

.68

.536

Participant B

143

145

146

+3

Participant C

213

215

212

-1

Participant D

150

148

145

-5

Participant E

232

230

230

-2

Participant F

226

230

230

+4

Participant G

336

329

315

-21

Participant H

256

251

255

-1

Participant I

213

210

209

-4

The weight at pretest ranged from 143 to 336 pounds, with the weights at posttest
ranging from 145 to 329 pounds. The weight at the 3-week follow-up ranged from 145 to
315 pounds. Weight changes from pretest to the 3-week follow-up ranged from a loss of
21 pounds to a gain of 4 pounds. Two participants gained weight, while seven
participants lost weight. The results of the repeated measures ANOVA , F (2, 7) = 0.68, p
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= 0.536 indicates that although the participant’s weight varied across the three time
periods, the changes were not statistically significant.
The participants were asked to record their physical activity at pretest, posttest,
and at 3-week follow-up. Their self-reports were summarized using descriptive statistics
for inclusion in Table 5.
Table 5
Self-report of Physical Activity at Pretest, Posttest, and 3-week Follow-up
Pretest
Physical Activity

Posttest

3-Week Follow-up

Mean

SD

Mean

SD

Mean

SD

Sleep, Rest

350.00

82.16

391.67

86.96

368.33

59.58

Sitting, Watching TV

220.00

134.16

268.33

126.05

286.67

122.65

Working at desk

186.67

94.31

235.00

141.11

233.33

144.48

Cooking, Standing

171.67

82.54

151.89

90.96

145.00

100.34

Light cleaning

148.33

114.35

181.67

112.86

155.00

77.22

Bicycling

13.33

20.46

56.67

55.51

38.33

42.50

Gardening

55.00

44.37

45.00

48.61

35.00

36.74

Aerobics

46.67

37.83

40.00

49.18

53.33

95.49

6.67

15.21

30.00

68.33

41.67

60.83

Running, Racing

The mean scores for six of the activities increased from pretest to posttest. At the
3-week follow-up, the mean scores for three of the activities (sitting, watching TV;
aerobics; and running, racing) increased from posttest to the 3-week follow-up. The time
spent in the remaining physical activities showed decreases from the posttest to the 3week follow-up.
Descriptive statistics were obtained on the participant’s self-report on the eight
measures on appetite scale. Table 6 presents results of this analysis.
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Table 6
Self-Report of Appetite at Pretest, Posttest, and 3-week Follow-up
Pretest

Posttest

3-week Follow-up

Mean

SD

Mean

SD

Mean

SD

Hungry

37.19

22.45

35.63

18.74

24.22

13.13

Satisfied

37.67

20.12

34.74

18.65

39.19

20.07

Full

37.26

28.48

27.70

19.94

37.85

26.60

Eat

46.96

15.30

44.37

11.96

42.07

13.52

Sweet

70.11

19.13

71.19

18.54

71.96

17.60

Salty

76.33

18.83

79.26

20.19

79.26

20.19

Savory

82.89

19.83

86.07

18.91

81.37

20.68

Fatty

78.59

17.50

80.07

20.45

79.37

23.78

Note: Anchor points for each of the scale items are included in Appendix A.

The mean scores on the self-reported measures on appetite changed in the
appropriate direction. For example, the participants had higher scores for the hungry item
at pretest than at posttest and the scores further decreased at the 3-week follow-up. This
finding indicated that participants tended to feel less hungry over the course of the study.
The item, how full do you feel, the participants’ self-reports decreased from the pretest to
the posttest and then increased at the 3-week follow-up, indicating that the participants
were less full at posttest and felt fuller at the 3-week follow-up.
Research Hypotheses
The study contained six research hypotheses. They are presented as follows:
H1:

Participation in cognitive-behavioral therapy for insomnia will improve
perceived sleep quality as measured by the Pittsburgh Sleep Quality Index
(PSQI) among post-menopausal females with type 2 diabetes.

H2:

Participation in cognitive-behavioral therapy for insomnia will improve
perceived insomnia severity as measured by the Insomnia Severity Index.
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H3:

Participation in cognitive-behavioral therapy will improve sleep quantity
as measured by the Actiwatch 2.

H4:

A relationship exists between change in perceived sleep quality as
measured by the PSQI and diabetes metabolic control as measured by
A1C among post-menopausal females with type 2 diabetes.

H5:

A relationship exists between change is sleep quality as measured by the
PSQI and activity as measured by the Physical Activity Scale among postmenopausal females with type 2 diabetes.

H6:

A relationship exists between change in perceived sleep quality as
measured by the PSQI and appetite as measured by the Visual Analog
Scale among post-menopausal females with type 2 diabetes.
Analysis of Data

The analysis of data is presented according to each research hypothesis:
H1:

Participants in cognitive-behavioral therapy for insomnia will improve perceived
sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI) among
post-menopausal females with type 2 diabetes.
The following components of the PSQI were individually scored to determine the

global score:








Subjective sleep quality
Sleep latency
Sleep duration
Habitual sleep efficiency
Sleep disturbances
Use of sleeping medications
Daytime dysfunction
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The global scores for the PSQI at the three data points were used in a repeated
measures ANOVA. Global scores > 5 represents poor sleepers and < 5 represents good
sleepers. The results of this analysis are presented in Table 7.
Table 7
PSQI at Pretest, Posttest, and 3-week Follow-up
Time

N

Mean

SD

DF

F Ratio

Sig

Pretest

9

2.89

1.27

2, 16

3.21

.067

Posttest

9

2.33

1.12

3-Week Follow-up

9

2.00

1.00

The comparison of the three times for the global PSQI scores was not statistically
significant, F (2, 16) = 3.21, p = 0.067. However, when the three time periods were
compared, the scores decreased from pretest (m = 2.89, sd = 1.27) to posttest (m = 2.33,
sd = 1.12), and continued to decrease to the 3-week follow-up (m = 2.00, p = 1.00). A
graph of the change in sleep quality across the three time periods is presented in Figure 6.

Figure 6 - Change in sleep quality over three time periods
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H2:

Participation in cognitive-behavioral therapy for insomnia will improve perceived
insomnia severity as measured by the Insomnia Severity Index.
A repeated measures analysis of variance (ANOVA) was used to determine the

extent to which changes in insomnia occurred as a result of participating in the study. The
participants completed the Insomnia Severity Index (ISI) three times, at pretest, posttest,
and 3-week follow-up. The total scores for the ISI were a composite score of the
components that were measured:








Difficulty falling asleep
Difficulty staying asleep
Problem waking up too early
Satisfied/dissatisfied with sleep pattern
Interfere with daily functioning
Quality of life impairment
Worried/distressed about current sleep.

The total scores on the ISI could range from 0 to 28, with higher scores indicating greater
severity of insomnia. The guidelines for determining the severity of insomnia are:





0-7
8-14
15-21
22-28

=
=
=
=

No clinical significant insomnia
Subthreshold insomnia
Clinical insomnia (moderate severity)
Clinical insomnia (severe).

Table 8 presents results of the repeated measures ANOVA.

Table 8
Insomnia Severity – Pre, Post, and 3 Week Follow-up (N = 9)
Time

Mean

SD

DF

F Ratio

Sig

2, 16

15.69

.003

Pretest

18.44

4.50

Posttest

9.78

4.63

3-Week Follow-up

6.89

4.22
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The results of the comparison of the mean scores for these three measures of
insomnia severity were statistically significant, F (2, 7) = 15.69, p = 0.003. The large
effect size provided support that in addition to statistical significance, the change in
insomnia severity over the three time periods also had practical significance. The mean
scores for insomnia severity was 18.44 (sd = 4.50) at pretest with a decrease to 9.78 (sd =
4.63) at posttest. At the three week follow-up, the mean score had decreased further to
6.89 (sd = 4.23). Figure 7 presents a graphic representation of the change in insomnia
severity scores over the three time periods.

Figure 7 – Comparison of Insomnia Severity over Three Time Periods
H3:

Participation in cognitive-behavioral therapy for insomnia will improve sleep
quantity as measured by the Actiwatch 2.
Data from the Actiwatch 2 measuring sleep quantity (in minutes) were obtained

for each week of the study and again at the 3-week follow-up. To determine the change in
sleep quantity over the time of the study was tested using a repeated measures analysis of
variance. Table 9 presents results of this analysis.
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Table 9
Total Sleep Time (In Minutes) Over Duration of Study
Week

Number

Mean

SD

DF

F Ratio

Sig

Week 1

9

355.60

88.40

7, 56

2.24

.044

Week 2

9

336.80

60.75

Week 3

9

325.07

59.72

Week 4

9

334.47

63.01

Week 5

9

320.40

50.18

Week 6

9

313.93

66.48

Week 7

9

316.47

56.44

3-Week Follow-up

9

330.13

51.47

The comparison of the total sleep time for the seven weeks of the study and 3-week
follow-up was statistically significant, F (7, 56) = 2.24, p = 0.044. This result indicated
that the number of minutes trended downward across the time of the study. At week 1,
the mean number of minutes of sleep was 355.60 (sd = 88.40). At week 7, the mean
number of minutes of sleep had decreased to 316.47 (sd = 56.44). At the three-week
follow-up, the mean number of minutes of sleep had increased to 330.13 (sd = 51.47).
Figure 8 illustrates the change in the number of minutes of sleep over the 11 weeks of the
study.
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Figure 8 - Change in quantity of sleep over term of study

H4:

A relationship exists between change in perceived sleep quality as measured by
the PSQI and diabetes metabolic control as measured by A1C among postmenopausal females with type 2 diabetes.
Pearson product moment correlations were used to determine the strength and

direction of the relationship between the change in perceived sleep quality from pretest to
the three-week follow-up and diabetes metabolic control as measured by A1C from
pretest to posttest. The results of this analysis produced an r-value of -0.29 (p = 0.446),
which was not statistically significant. The negative correlation suggested that higher
change scores for sleep quality were associated with lower levels of A1C.
H5:

A relationship exists between change in perceived sleep quality as measured by
the PSQI and activity as measured by the Physical Activity Scale among postmenopausal females with type 2 diabetes.
Pearson product moment correlations were used to examine the strength and

direction of the relationships between the changes in perceived sleep quality and the
measures of physical activity at pretest, posttest, and 3-week follow-up. Table 10 presents
results of this analysis.
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Table 10
Change in Sleep Quality and Physical Activity at Pretest, Posttest, and 3-Week Follow-up
Sleep Quality Index
Pretest

Posttest

3-week Follow-up

Physical Activity Scale

n

r

p

n

r

p

n

r

p

Sleep, Rest

9

.44

.235

9

-.08

.842

9

-.38

.309

Sitting, Watching TV

9

.00

1.000

9

-.29

.444

9

-.29

.450

Working at desk

9

-.07

.854

9

.22

.565

9

.52

.148

Cooking, Standing

9

.24

.535

9

-.26

.502

9

.07

.866

Light cleaning

9

.02

.958

9

-.17

.663

9

.15

.702

Bicycling

9

-.58

.105

9

-.07

.849

9

-.46

.216

Gardening

9

-.14

.720

9

-.06

.889

9

-.46

.216

Aerobics

9

-.45

.227

9

.45

.225

9

-.69

.040

Running, Racing

9

-.59

.094

9

.50

.166

9

.17

.672

One statistically significant correlation was obtained between change in sleep
quality and participation in aerobics at 3-week follow-up (r = -0.69, p =0.040). This result
indicated that as time spent in aerobics exercise increased, the change in sleep quality
(lower scores indicate improved sleep quality) showed improvement. The remaining
correlations were not statistically significant, although some suggested moderate to
strong relationships. Correlations between .40 and .60 are considered to be moderate to
strong.
H6:

A relationship exists between change in perceived sleep quality as measured by
the PSQI and the appetite as measured by the Visual Analog Scale among postmenopausal females with type 2 diabetes.
The data on the Visual Analog Scale were analyzed for each item on the scale.

Data were collected for three days at each data collection point (pretest, posttest, and 3-
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week follow-up). The mean scores for the three collection days at each data point were
used to analyze the relationship of appetite and sleep quality (PSQI) global score using
Pearson product moment correlations. Table 11 presents results of this analysis.

Table 11
Change in Sleep Quality and Appetite at Pretest, Posttest, and 3-week Follow-up
Sleep Quality Index
Pretest

Posttest

3-week Follow-up

Appetite Scale

n

r

p

n

r

p

n

r

p

Hungry

9

.21

.592

9

.52

.148

9

-.30

.435

Satisfied

9

-.23

.554

9

.02

.951

9

.51

.158

Full

9

-.21

.589

9

-.38

.324

9

.01

.991

Eat

9

.14

.720

9

-.23

.555

9

-.11

.782

Sweet

9

-.34

.376

9

-.83

.005

9

-.29

.445

Salty

9

.10

.794

9

-.07

.862

9

-.06

.879

Savory

9

.07

.863

9

-.22

.563

9

-.20

.603

Fatty

9

-.30

.433

9

-.14

.713

9

-.23

.545

Note: Anchor points for each of the scale items are included in Appendix A.

One statistically significant correlation in a negative direction between appetite
for sweet food and sleep quality (global PSQI score) was obtained at posttest (r = -0.83, p
= 0.005). A negative relationship was reported as a lower quality of sleep score indicated
better sleep quality and a higher score for appetite for sweets indicated a lesser appetite
for sweets. The remainder of the correlations were not statistically significant.
Ancillary Findings
Pearson product moment correlations were used to determine if there was a
relationship between the insomnia severity index from pretest to posttest and at the 3-
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week follow-up and the A1C levels at pretest and posttest. The results of this analysis are
presented in Table 12.
Table 12
Severity of Insomnia and A1C
Insomnia Severity
Pretest

3-week Follow-up

A1C

n

r

p

Pretest

9

-.16

.678

3-week Follow-up

n

r

p

9

.31

.412

Inverse relationships were found at pretest between the insomnia severity and the
AIC (r = -.16, p =.678). The inverse relationship suggested that higher A1C levels were
associated with lower scores on the insomnia severity index. In contrast, at the 3-week
follow-up, a positive relationship was obtained between A1C and the insomnia severity
index (r =.31, p = .412). This moderate relationship indicated that lower scores on the
A1C were associated with lower scores on the insomnia severity index. Neither
relationship was statistically significant.
Summary
The results of the data analyses that were used to describe the sample and test the
hypotheses that were established for the study have been presented in this chapter.
Conclusions and recommendations based on these findings can be found in Chapter 5.
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CHAPTER 5
DISCUSSION
Introduction
In this chapter the results of the study are discussed beginning with the sample
description. Additional findings, conclusions, limitations of the study, suggested study
design changes, and implications for nursing practice are then presented. The chapter
concludes with recommendations for future research.
Summary of Research Findings
The purpose of this feasibility study was first to determine the impact of a seven
week cognitive behavioral therapy intervention on the sleep behaviors of women aged
50-75 years of age with type 2 diabetes. The outcomes of this intervention were then
analyzed for relationships of change in sleep quality on metabolic control, appetite and
physical activity.
Although the target sample size was 24 women aged 50-75 years of age, 18
women consented to be in the study and nine women aged 56-69 years of age completed
the intervention and the three-week follow-up. Of the nine women who completed the
study, most were married, educated and had insurance. Each of the women reported
insomnia for at least six months and type 2 diabetes for a minimum of one year.
Following extensive recruitment efforts (newspaper and radio advertisements and
visits with diabetes educators, primary providers, diabetes support groups, and
community diabetes programs) over a 14-month period, the decision was made to close
the study to new participants.
A variety of reasons could account for the limited number of study participants.
The sample criteria limited participants to women aged 50-75 years of age who had
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insomnia for a minimum of six months and type 2 diabetes for a minimum of one year.
Advertising materials specifically stated that participants needed to be female. Yet, men
responded to the newspaper and radio advertisements requesting to be in the study. At
recruitment activities, potential participants reported that they weren’t interested in
committing to a study that lasted 11 weeks. Retired women often compensate for poor
sleep by going back to bed in the morning and taking naps. Since they do not need to get
up in the morning and stay awake as they would when working, the need to experience a
quality 7-8 hours of sleep is not as important to them. In addition, the relationship of poor
quality and quantity of sleep to diabetes and general good health is not well established in
our society. Doctors often do not assess sleeping behaviors of their patients, and
therefore, do not provide recommendations regarding sleeping habits. In addition, fatigue
is the symptom of insomnia. Senior citizens often believe that fatigue is associated with
aging rather than a symptom of poor quality sleep. Therefore, the need to decrease the
severity or eliminate insomnia is often not perceived as a major concern.
The women, as a group, reported improved sleep following the seven week
intervention. Although not statistically significant, the Pittsburgh Sleep Quality Index
(PSQI) results indicated that the women experienced improved sleep at both the posttest
and 3-week follow-up data collection points. The PSQI reports overall quality of sleep as
related to good and poor sleepers. Those who report a global score >5 are considered
poor sleepers. The Insomnia Severity Index (ISI) results did indicate that the severity of
insomnia began at a clinical level of moderate insomnia, decreased to a sub threshold
level at the posttest and further decreased to no insomnia at the conclusion of the study.
The statistical results were significant with a sample size of 9. Based on the results of this
analysis, the null hypothesis of no change in insomnia severity over the three time
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periods is rejected. This supports findings in the literature that reports that CBTI is an
effective treatment for insomnia (Morin et al., 2006).
The women in the study wore Actiwatch 2 devices to objectively record their
sleep time. The amount of sleep in minutes was recorded weekly during the study and at
3-week follow-up. A repeated measures analysis of variance was used to determine if the
sleep times varied across the time of the study. The results of this analysis were
statistically significant, F (7, 56) = 2.24, p = .044. Figure 9 presents the sleep times across
each week of the study.

Figure 9 - Minutes of Sleep across the Study
The mean sleep duration at the first week of the study was 355.60 (sd = 88.40)
minutes (5.93 hours). At the end of the 3-week follow-up, the mean sleep duration was
330.13 (sd = 51.47) minutes (5.50 hours). Although the mean number of minutes of sleep
duration had decreased from the beginning of the study to the follow-up, the change from
the seventh week to the three-week follow-up showed an increase of 14 minutes. While it
appears that the sleep duration decreased significantly, sleep restriction may have been
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the reason for the decrease in sleep quantity. The use of sleep restriction is designed to
improve sleep efficiency by decreasing total time in bed. After baseline data are collected
during the first week of the study, the average total sleep time is used to determine the
total time in bed. The principle is that the person will be very tired at bedtime and sleep
consolidation will occur. Continuation of a regular bedtime and wake time helps the
person develop a consistent circadian rhythm. An increase of 15 minutes in total sleep
time is recommended when the sleep efficiency is 90% or above. If the sleep efficiency
falls below 85%, the recommendation is to decrease the total time in bed by 15 minutes.
Although the recommendation to determine the specific time in bed is to start with the
time that the person wishes to wake up and get out of bed and then count backwards to
determine the bedtime, participants in this study found that they were not able to stay
awake till the recommended bedtime. Therefore, the actual recommended bedtime and
wake up time were determined by starting with the bedtime and then counting forward.
Participants in cognitive-behavioral therapy are advised that their sleep may worsen
before it improves as a result of sleep restriction. Establishing a routine bedtime and
awakening has been found to take a minimum of three weeks into the intervention (Morin
& Espie, 2004). Cognitive behavioral studies typically include a 6 month and one year
follow-up as over time the sleep duration has been reported to increase (Morin, et
al.,2006). A three week follow-up was included in this study based on expected change in
the hemoglobin A1C test which is reported to occur at ten to twelve week intervals.
Pearson product moment correlation was used to determine the strength and
direction of the relationship between change scores for perceived sleep quality and
diabetes metabolic control as measured by A1C. A correlation of -0.29 (p = .446) was
obtained indicating that higher A1C levels were associated with lower change scores for
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perceived sleep quality. In addition, the A1C levels at pretest ranged from 5.8 to 8.3, with
levels at the 3-week follow-up ranging from 5.6 to 7.8. Eight of the nine participants,
including the participant that began the study with an A1C level of 5.8, experienced
decreases in their A1C levels. Three of the nine participants may have had further
lowering of their A1C levels as they had reductions in the dosage of their diabetes
medications. From a clinical perspective, this finding is promising.
Pearson product moment correlations were used to test the direction and strength
of the relationship between perceived sleep quality and activity as measured by the
Physical Activity Scale at pretest, posttest, and 3-week follow-up. One statistically
significant correlation was obtained between participation in the category aerobics and
perceived sleep quality at the 3-week follow-up, r = -.69, p = .040. Only the category of
running,racing was a more rigorous activity reported on the scale. The mean number of
minutes spent in aerobic activity at pretest was 6.67. This increased to 30 minutes at the
posttest and then an increase to 41.67 minutes at the three-week follow-up. Although not
statistically significant, the mean number of minutes in six of the other seven categories
increased from pretest to three-week follow-up. Although Chasens, Sereika, Weaver, &
Umlauf (2007) found that sleepiness was associated with decreased exercise, fatigue is
the symptom associated with insomnia. Women in the age group studied, tended not to be
less physically active than younger adults. No studies relating amount of exercise to
severity of insomnia were found in the literature.
The correlations between the PSQI and the eight measures of appetite provided
evidence of one statistically significant direct correlation between appetite for sweet food
and sleep quality at posttest (r = .83, p = .005). Since carbohydrate foods increase blood
sugar, increased appetite for sweets is of significant concern for people with type 2
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diabetes. Other correlations were stronger than expected, but were not statistically
significant because of the small sample size. Figure 12 presents the appetite measures at
pretest, posttest, and 3-week follow-up.
The first four appetite measures reported participants’ hunger, satisfaction,
fullness and amount they could eat before breakfast. The first of the eight measures on
the appetite visual analog scale was “How hungry do you feel?” Higher scores indicated
that the participant was “more hungry.” The participants had higher scores for this item at
pretest than at posttest. The scores further decreased at the 3-week follow-up. This
finding indicated that participants tended to feel less hungry over the course of the study.
“How satisfied do you feel?” was the next measure to be evaluated. Higher scores
indicated that the participant was more satisfied. Although the posttest scores were lower
than the pretest scores, the three-week follow-up scores increased, indicating participants
were more satisfied at the conclusion of the study. The third item on the visual analog
scale was “How full do you feel?” Higher scores indicated that the participant was closer
to being totally full. The scores at pretest were lower than posttest, but then higher at the
3-week follow-up. The indication was that the participants were closer to feeling full at
the conclusion of the study. “How much do you think you can eat?” was item number
four on the visual analog scale. Lower scores indicated that the participant was able to eat
less. The scores lowered from pretest to posttest and then again at the 3-week follow-up.
The participants reported feeling that they could eat less at the conclusion of the study
than at the beginning. These findings are of clinical value. The quantity of food intake for
women with type 2 diabetes is reported to often be greater than the recommended
amount, resulting in increased blood sugar levels and weight gain. A decreased appetite is
helpful in reducing food intake.
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The next four appetite measures relate to appetite for types of food (sweet, salty,
savory and fatty). Item five on the visual analog scale was “Would you like to eat
something sweet?” Higher scores indicate that the participant did not want to eat
something sweet. The participants reported that they were less likely to eat something
sweet at the posttest than at the pretest. At the 3-week follow-up the participants were
less likely to eat something sweet than at the posttest. “Would you like to eat something
salty?” was item number six. The higher scores indicated that the participant was less
likely to eat something salty. The results indicated that the participants were less likely to
eat something salty at the posttest than at the pretest. Results at the 3-week follow-up
were the same as at the posttest showing no change during this 3-week period. Since most
people with diabetes also have hypertension, this relationship is important clinically. Item
seven on the analog scale was “Would you like to eat something savoury?”. The higher
scores indicated that the participant was less likely to eat something spicy. The
participants reported that they were more likely to eat something savoury at the posttest
than at the pretest. At the 3-week follow-up, they were less likely to eat something
savoury than at the pretest. “Would you like to eat something fatty?” was item number
eight. The higher scores indicated that the participant was less likely to eat something
fatty. The scores were higher at the posttest than at the pretest. Lower scores were
reported at the 3-week follow-up than at the pretest. The scores indicate that the
participants were less likely to eat something fatty at the 3-week follow-up than at the
pretest. See Figure 10 for a graphical representation of the three time periods.
Earlier research by Spiegel, Tasali, Penev, & Van Cauter (2004) reported that
sleep curtailment in healthy young males was associated with increased hunger,
especially for sweets. Although this study looked at sleep quality in relationship to
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appetite markers, hunger for sweets was found to have a statistically significant
correlation. Further research in this area is recommended as this study found a
relationship between sleep quality, rather than sleep quantity, and an appetite for sweets.

Figure 10- Appetite Measures at Pretest, Posttest, and 3-Week Follow-up
Additional Findings
The relationship between the A1C levels and insomnia severity was tested at
pretest and 3-week follow-up. The relationship at pretest was low (r = -.16, p = .678), but
increased substantially at posttest (r = .31, p = .412). At pretest, the negative relationship
indicated that higher insomnia severity was associated with lower A1C levels. In contrast,
at the 3-week follow-up, the relationship became positive, indicating that lower A1C
levels were related to lower insomnia severity. As the sample was quite small, reasons for
the low negative relationship at pretest were unclear. The desired outcome was that lower
insomnia severity would be related to lower A1C levels, providing beginning evidence
that improved insomnia severity was associated with improved metabolic control as
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evidenced by lower A1C levels. These results support the need for additional research
with a larger sample.
Conclusions
Although not statistically significant, an improvement in self-reported overall
sleep quality was found at the completion of the cognitive behavioral therapy
intervention. An improvement in overall sleep quality with a small sample suggests that
further research with a larger sample size is needed to better understand this finding. The
PSQI global scale scores indicate overall sleep quality. Thus, the results of the PSQI are
not specific to quality of sleep for those with insomnia. Therefore, perceived insomnia
severity was also measured.
Cognitive-behavioral therapy for insomnia was found to improve self-reported
insomnia severity. Using ANOVA, the comparison of the mean scores for the three
measures of insomnia severity were statistically significant, F (2,7) = 15.69, p = .003.
The insomnia severity at the pretest was reported to be moderate severity clinical
insomnia. At the posttest the participants had moved to sub threshold insomnia. At the
conclusion of the study, the participants reported, as a group, to have nonclinical
insomnia. This supports a large body of research indicating that cognitive behavioral
therapy for insomnia is an effective method of treatment for insomnia (Epsie et al., 2008)
and is beginning evidence that CBTI has potential for treating insomnia in aging women
with type 2 diabetes.
Although sleep quantity, as reported by the Actiwatch 2, did decrease during the
study, the total sleep time began to improve by week seven. This was an expected result
with the use of sleep restriction. The behavior changes needed to develop healthy sleep
habits included learning to sleep without a television playing and not watching television
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during the night, going to bed at a regular time, avoiding alcohol and caffeine from
dinner to bedtime, and awakening at a regular time are major behavior changes. Some
participants had support from family members, and in some situations, family members
were barriers to behavior change. Some of the participants had experienced insomnia
with poor sleep habits for many years. One of the participants reported frequently not
sleeping more than one or two hours per night. As one participant reported. “This is a
work in progress”. For future studies a longer follow-up period is recommended as sleep
duration following CBTI has been reported to increase over time (Epsie et al., 2008).
Each method of collecting sleep data has limitations, therefore, participants also
maintained sleep diaries. The Actiwatch 2 devices did not record all changes including
evening napping and morning resting in bed. The Actiwatch was more accurate at
determining total sleep time from bedtime till arising in the morning as participants had
difficulty knowing how long they were awake during the night. Thus, the two methods of
recording sleep behaviors complemented each other.
The change in perceived sleep quality as measured by the PSQI and diabetes
metabolic control as measured by A1C among aging females with type 2 diabetes was
analyzed using Pearson product moment correlations. A negative correlation indicated
that higher change scores for sleep quality were associated with lower levels of A1C.
Although the results were not statistically significant, eight of the nine participants
experienced a decrease in A1C levels. Three of these participants also experienced
reductions in their diabetes medication dosages. Since the ISI scale is for measuring
insomnia, this tool was also used. A moderate relationship between insomnia severity and
A1C levels at the 3-week follow-up were found. Thus, lower A1C levels were associated
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with lower scores on the ISI. The small sample size may be responsible for not obtaining
statistically significant results.
The physical activity scale was used to gather data pretest, posttest and 3-week
follow-up. The category of running/racing on the Physical Activity Scale was found to
have a statistically significant correlation between change in sleep quality as reported by
the PSQI at the three-week follow-up (r = -.69, p = .040). The number of minutes in
seven of the nine activity categories did increase from pretest to 3-week follow-up. The
expectation was that participants would be less active with poor quality of sleep.
Beginning evidence suggests that improved quality of sleep may improve physical
activity, especially in the running/racing category. Further investigation with both a
larger sample and over a longer period of time is recommended.
Appetite was measured using the Visual Analog Scale before breakfast at each of
the data collection points to determine if improved sleep quality changed appetite
reported for each of the eight appetite measures. Results indicated that participants tended
to feel less hungry, more satisfied, closer to feeling full, could eat less, were less likely to
eat something sweet, just as likely to eat something salty, less likely to eat something
savory and less likely to eat something fatty at the completion of the study. The one
measure that reported statistical significance at the three-week follow-up was appetite for
something sweet. As metabolic control of diabetes is strongly impacted by food intake,
these results provide evidence that further research in this area is needed with a larger
sample size. The finding that improved quality of sleep is positively associated with a
decreased appetite for sweets is of particular importance clinically as carbohydrates
increase blood sugar levels. Thus, this statistically significant relationship is also
clinically significant.
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Weight scores were also obtained at the three measurement points to provide
additional information regarding nutritional status. The participant’s weights remained
relatively stable over the 11 weeks of the study. Seven participants lost weight during the
study and two gained weight. One participant lost 21 pounds during the study
unintentionally, while one participant gained four pounds and another gained three
pounds. The results of repeated measures ANOVA were not statistically significant,
providing additional evidence of the stability of weight across the study.
Limitations
Limitations of this study include a small sample size, no control group and a short
follow-up time period. Although a target sample size of 24 women 50 to 75 years of age
was needed for statistical power, nine participants completed the intervention and all data
measurement periods. Hypotheses #1, 2, 5 and 6 used self-reported data. The budget for
this study limited the use of additional data collection methods such as a polysomnogram
for the measurement of sleep quantity and/or continuous glucose testing to further
evaluate changes in blood sugar during each 24 hour day of the study. As the sample size
was small, increased sample size may result in improved statistical results. Previous
studies, using cognitive behavioral therapy to improve sleep behaviors of those with
insomnia, found improved quality and quantity of sleep at the 6 month and 1 year followup data collection points. Since women with A1C levels of 9% or less were included in
the study, those with higher A1C levels were excluded from the study. Research has
reported those with poor sleep tend to have higher A1C levels (Vigg, Vigg, & Vigg,
2003). Lowering an A1C level is easier when the A1C is higher at baseline. Lowering
and A1C that is 5.8 at baseline (participant #2) is more difficult. In addition, the sample
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was limited to women aged 50 to 75 years of age who had both type 2 diabetes and
insomnia. Therefore this study cannot be generalized to the overall population.
Suggested Changes in the Feasibility Study
Results of this study indicate that further research with a larger sample is
recommended. Changes in recruitment and intervention sessions, in addition to including
a six month and a one year follow-up data collection times are suggested. Although
extensive recruitment was conducted, a change in the wording (Sleep Study to Insomnia
Study) on the study flyer and newspaper advertisements may have been helpful.
Including the tool on motivation for change questionnaire to the orientation session rather
than the first intervention session may be helpful in decreasing the drop-out rate.
Obtaining sleep data using a polysomnogram as part of the orientation would confirm
that participants did not have obstructive sleep apnea or another undiagnosed sleep
disorder. In terms of the intervention, the session on relaxation may be more beneficial
earlier in the intervention as many of the participants reported the need to relax. Inviting
participant partners (co-sleepers) to one of the sessions might improve partner support.
Clinically the order of sessions can be individualized when providing CBTI individually.
This may be a consideration for future research. Participants reported feeling better at the
end of the intervention. Including both a depression tool and a fatigue questionnaire may
provide insight into this participant response. In addition, including home
polysomnography would provide information regarding the impact of sleep states on
reported sleep quality. Adding the six month and one year follow-up sessions would
provide longer term results. Although there are some reported differences in sleep
behaviors between men and women, it is suggested that the sample be expanded to
include both sexes that have insomnia and type 2 diabetes. It is also suggested that in
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future research the sample be expanded to include women with diabetes at younger ages.
Although pre and peri-menopausal women have sleep issues associated with their
physical life changes, they often are more stimulated to improve sleep behaviors. In
addition, once a person lives with poor sleep for an extended period of time, changing
sleep behaviors becomes more difficult.
Implications for Nursing Practice
Nurses are involved in the care of people with diabetes in many settings. The need
to assess both the quality and quantity of sleep of people with diabetes is important
regardless of the setting. This study provides additional evidence that perceived sleep
quality has a relationship to diabetes metabolic control. Therefore nurses need to be
educated to assess sleep behaviors of people with diabetes and refer their clients to sleep
specialists as appropriate. Certified nurse diabetes educators have a special role in this
area. With training in sleep behaviors, especially cognitive behavioral therapy for
insomnia, certified diabetes educators could provide both insomnia and diabetes selfmanagement education for people experiencing both chronic diseases (Roth, 2009).
Recommendations for Further Research
This study suggests that there is a relationship between perceived improved sleep
quality and improved diabetes metabolic control. A study with a larger sample size and
also 6-month and 1-year follow-up times is recommended to obtain statistical
significance. Additional studies are recommended to include both men and women of
differing ages as this study was limited to aging females. Another factor to be studied is
the effect of the duration of both diabetes and insomnia on the intervention outcomes.
Lastly, research that combines both CBTI and diabetes counseling is recommended as
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this combined treatment might be expected to have a greater impact on metabolic control
and insomnia (Roth, 2009).
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Sleep Study
Do you have trouble getting to sleep
and staying asleep?
Are you a woman aged 60 to 70 years of age?
Do you have type 2 diabetes?
Consider enrolling in an 11 week study.
Possible benefits are:
 You sleep longer
 You sleep through the night.
If you are interested in learning more about the
study:

Call: Cheryl Tannas at:
(313) 530-9895.
334 Cohn Building
Wayne State University
Detroit, MI 48202
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Sleep and Metabolic Control
April 2011

Initial Screening
Individuals will be evaluated using the screening tool (Study Manual, p 22) either
by phone or in person to determine eligibility to attend a study orientation session.
For those meeting the initial screening criteria, additional assessment at the orientation
session will determine final intervention eligibility.

Intervention Outline/Dialog
Orientation

Goals:
Determine if potential study participant meets the criteria of the study.
If so,
Obtain signed consent.
Collect data
Schedule intervention sessions
Presenter: Cheryl Lee Tannas
Time: 15-20 minutes
1. Introduction of the Sleep and Metabolic Control study to potential study
participants. Introduction of the study author, explanation of the study, purpose
risks, benefits, freedom to decline participation in the study without
consequences, experimental groups and activities. Signature of the consent form.
Dialog:
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“My name is Cheryl Tannas. I am a doctoral student in the college of Nursing at
Wayne State University. The purpose of this study is to determine if improved sleep
behaviors are related to diabetes metabolic control. The study is part of my requirements
to complete my doctoral education. I am conducting a study of women, aged 60 to 70
years of age with type 2 diabetes and disrupted sleep to learn better ways to assist women
in managing their type 2 diabetes. I am a nurse who is certified as a diabetes educator and
was trained in Cognitive Behavioral Therapy for Insomnia at the University of Michigan
”
“The known risks to participating in this study are minimal. The
possibility of emotional discomfort associated with answering some of the
questions does exist. The other possible risk is that of bruising or possibly
infection at the site where the small sample of blood will be obtained.
There are many potential benefits to participating in the study. The two
major potential benefits are improved sleeping and improved diabetes
control.”
“You have the freedom to decline participation in the study without
consequences. Your participation is completely voluntary. Your data will
be identified only by a study code number and maintained is a secure
location. If you choose not to participate, you will not be penalized in any
way.”
“If you want to participate in the study, you need to sign the consent
form (Study Manual, p31) before we can go further with the orientation.
Please keep in mind that a final decision as to your study participation
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will be determined at the end of the orientation session. If you chose, we
will go over the consent form together.”
If the potential study participant decides to sign the consent form the
orientation session will continue. If the individual decides not to sign the
consent form she will be thanked for her interested and wished the best of
luck in the future.
Signed Consent
Time: 5-10 minutes
“Since you have decided to sign the consent form we will go over it
together before you sign. You will be given a copy for your records.”
Review of the consent form will then occur.
Screening
Time: 40 minutes
“To further determine whether this intervention may be of benefit to
you I will ask you questions about your sleeping behaviors and also about
your general health. The Medical History Checklist (Study Manual, p. 25)
will be completed and a sleep history will be taken using the Sleep History
Guide (Study Manual, p.27).”
Data Collection
Time: 40 minutes
“There are a couple of survey tools (Pittsburgh Sleep Quality Index
and the Insomnia Index, Study Manual pp.38&41) that you need to
complete now, at the end of the study and four weeks following the end of
the study. Two other forms will be used during the study to evaluate your
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appetite (Study Manual, p. 42) and exercise activity (Study Manual, p.43).
In addition I will draw blood to do an A1C test and obtain your current
weight. If your A1C is more than 9, you will need to see your doctor to
develop a plan to lower your blood sugar. Once your A1C is 9 or less you
are eligible to participate in the study.”
Baseline Data
Time: 30 minutes
“To prepare for the study you will need to collect some information for
three days prior to session 1. This includes completing a daily sleep diary
(Study Manual, p.36), checking your blood sugar before each meal and
before you go to bed for the evening, wearing a device that measures your
sleeping patterns and completing a form about your appetite before each
meal and at bedtime. Now we will review the use of the sleep diary.(The
Sleep Diary will be explained). Are you comfortable completing this form?
If so, I will review the use of the blood glucose meter that you are asked to
use for this study. You will also be provided with strips to test your blood
sugar. Both demonstration and return demonstration of the blood glucose
meter will occur. Next we will review the form to evaluate your appetite.
(Each form will be explained). Before you begin our weekly meetings, will
you please complete these forms for 3 consecutive days? Do you have any
questions at this time? (answer questions) The only issue left is to set dates
and times for our seven weekly meetings. (meetings will be scheduled)
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Intervention
Session 1
Presenter: Cheryl Lee Tannas
Time: 90 minutes
1. Session Goals
Review Class Outline
Complete Motivation to Change and review with participant.
Complete Sleep Behavior Self-Rating Scale and review with participant
Collect data (sleep diary, VAS, blood glucose from the blood glucose meter
and actigraph results)
Assess sleeping behavior
Develop a sleep schedule for the participant
2. Session Content (dialog):
“I am so glad to see you. To begin with, did you have any problems completing
the sleep diary? (address any concerns) What about using the blood glucose meter or
wearing the actigraph? (address any concerns) Also, do you have any questions
about the VAS ? (address any concerns).”
“Before we begin with the information for tonight, I want to review the seven
classes that are part of this study. Provide and discuss the class outline (Study
Manual, p 45) designed for this study. An overview of the study content is provided on
the class outline. (Stress that some of the activities are more helpful to each person
than others are) You may want to refer to it in the future.”
“While I download your blood glucose meter and your wrist actigraph I’d like
you to complete two questionnaires(Motivation for Change and Sleep Behavior Self-
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Rating Scale – Study Manual pp 48 &49). After you complete the questionnaires we
will discuss your choices. (Discuss the completed questionnaires with the study
participant)”
“Next I’d like to discuss sleep restriction with you. The purpose of restricting
your sleep is to reshape your sleep so that it will meet your needs. This may be
challenging for you in the beginning, but it has been found to be quite effective for
many people. It is important to stabilize your sleep so that you can both increase the
amount and quality of sleep that you will experience on a regular basis.”
“To begin with let’s look at the sleep diary that you have been keeping. We can
determine how much sleep you are actually getting each night, when you usually go
to bed and when you usually get up in the morning. We can also look at any napping
that you are doing. (Look at the sleep diary with the participant. Determine what the
total sleep time is for this individual). When do you want to wake in the morning? It is
important to put this time into practice. To determine the time to retire we will
subtract your sleep time from your rising time. For you it is recommended that you go
to bed at ___ and wake up at ___. It is important that you follow this schedule seven
days each week. Napping is discouraged. Next week we will determine how well this
has worked for you and determine what changes to make.”
“A couple of more issues to consider when you sleep this week are that you only
go to bed when you are sleepy and that you observe the 15 minute rule. Although we
have determined a time for you to go to sleep, it is important that you are sleepy when
you go to bed. If you are not sleepy, then delay when you go to bed. Also, lying in bed
is one of the behaviors supports sleeplessness. Therefore, if you are not able to sleep
after 15 minutes, please get out of bed and do something that is relaxing. Reading is
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an example of a relaxing activity. Watching TV and using a computer tend to keep
people awake. What do you think will work for you?”
“Last but not least is the need to maintain this schedule for seven days each week.
Behavior change is accelerated by consistency across the week. Once a good sleep
habit is established it will be difficult to break. The longer that you use the techniques
that you will learn during out time together, the better you will be at getting a “good
night’s sleep”. Before you leave what questions do you have? If you have questions
during the week, you can call me at _______. Next week we will meet on _____ at
____. Sleep Well!”
Session 2
Presenter: Cheryl Lee Tannas
Time: 90 minutes
1. Session Goals
Complete Sleep Environment Checklist and review results with participant
Complete Caffeine Knowledge Quiz and review with study participant
Obtain Data (Sleep Diary, blood sugar results from the glucose meter and
actigraph results)
Assess treatment gains and barriers with study participant
Make adjustments in the participants sleep schedule
Discuss Stimulus Control Therapy with participant
Participant to set one goal associated with Stimulus Control Therapy
Discuss stimulus control therapy and participant set appropriate goals.
2. Session Content (dialog):
“Hello, (participant). So how did this past week go for you? (Answer
questions and review the sleep diary. Mutually agree on the new sleep schedule.
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Praise the participant for progress and assist in problem solving for the barriers
that occurred.)”
“Tonight/today we will discuss some of the factors that can either promote or
disrupt your sleep. To begin with will you please complete the Sleep Environment
Checklist and the Caffeine Knowledge Quiz(Study Manual pp51 & 53)? While
you do that I will download you blood glucose meter and the actigraph. Then we
will discuss the questionnaires.”
“Now that you have finished these two questionnaires, let’s talk about your
answers. (Review each of the answers on the Sleep Environment Checklist. Stress
that making the connection between sleep and the bed promotes sleep. The
bedroom needs to only be used for sleep. Sexual activity is the only exception to
this rule. Identify other barriers to sleep reported on the checklist.) Next we can
review the Caffeine Quiz. Caffeine is a strong stimulant that can prevent you from
sleeping. (Review that Caffeine quiz with the participant. Identify the appropriate
amounts of caffeine in the items listed on the quiz.)”
“In addition to caffeine, alcohol has been found to disrupt sleep. Do you use a
night cap in your bedtime routine? If yes: Alcohol has been found to awaken
people during the night if it is ingested too close to bedtime. If you choose to
consume some alcohol, dinner time is a good time to do this. Although drinking
needs to be in moderation, some people find that a glass of wine with dinner helps
them to relax before bedtime.”
“Other factors that have been found to disrupt sleep are being hungry and
being too full. Do you include a bedtime snack in your meal plan? If so, does it
seem to be helpful? Low blood sugar can wake you up during the night. Has this

96
happened to you? If you are not able to get back to sleep do you check your blood
sugar? Sometimes although you do not have symptoms of low blood sugar, it may
be low and therefore preventing you from going back to sleep. Also, how many
times did you say that you get up to go to the bathroom? When your blood sugar
is high, how often do you need to get up to go to the bathroom?”
“Based on what we have discussed during our time together are there any
changes in your bedroom and/or bedtime routine that you want to make? What
about your caffeine and/or alcohol use? (This is the time for the participant to
make a goal or more that is appropriate.)”
“What questions do you have for me? (Answer Questions) Do you have
enough blood sugar strips for the next week? According to my schedule our
meeting for next week is on ___ at _____. Is this correct? I’m looking forward to
seeing you next week. If you need to reach me, don’t hesitate to call.?”
Session 3
Presenter: Cheryl Lee Tannas
Time: 90 minutes
1. Session Goals
Complete the Pre-Sleep Arousal Scale and review the results with the
participant
Discuss overview of Cognitive Therapy with the participant
Collect data (sleep diary, blood sugar results from blood glucose meter and
actigraph results)
Assess treatment gains and barriers with participant
Make adjustments in the participants sleep schedule
2. Session Content (dialog)
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“It’s good to see you. Now that you have been in the study for a couple of
weeks, how are you sleeping? (Discuss) Is this anything like you expected?
(Discuss) Let’s take a look at your sleep diary to determine the goal for this
coming week. (Discuss treatment goals and barriers.) Determine sleep goal”
“While I download your blood glucose meter and your actigraph, will you
please complete the Pre-Sleep Arousal Scale (Study Manual, p54)? This week and
next we will talk about Cognitive Therapy. After you complete the questionnaire
we will discuss what this means and how it may be of help to you. (Download
blood glucose meter and actigraph. Participant will complete the Pre=Sleep
Arousal Scale)
“First, let’s look at how you completed the Pre-Sleep Arousal Scale. Before we
review each of your responses, are there any of the questions that caught your
attention? (Discussion) Some of the thoughts that you have may be helping or
hindering your sleep. If you have a thought or belief that is harmful, we can think
about a thought that may be more helpful. (Discussion) Next week we will review
more specific thoughts that may be helpful or harmful. Are you willing to write
down any thought that you experience this coming week? Will you please these
thoughts with you next week?”
“In summary, this coming week you will go to bed at____ and get up at _____.
You will record any negative thoughts that come to mind. Do you have any
questions about your sleep diary, blood glucose machine or actigraph? According
to my calendar you are scheduled to come back on___ at ____. Have a wonderful
week.”
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Session Four
Presenter: Cheryl Lee Tannas
Time: 90 minutes
1.

Session Goals

Complete Dysfunctional Beliefs and Attitudes about Sleep Scale and review.
Discuss dysfunctional beliefs about sleep
Collect data (sleep diary, blood glucose from
the blood glucose meter and actigraph results
Assess treatment gains and barriers
Make adjustments in the participants sleep schedule
2.

Session Content (dialog):
“Hello ____. How has your past week been? Did you write down some

negative thoughts or beliefs? (Discuss) Tonight while I download your blood
glucose meter and your actigraph, will you please complete the Dysfunctional
Beliefs and Attitudes about Sleep Scale (Study Manual, p 56)? This is a longer
questionnaire than the usual ones. We will review it when you are done. After that
we will go over your sleep diary and decide what your sleep schedule for this
coming week.”
“I am done downloading your blood glucose meter and your actigraph. Are
you done completing the questionnaire? (If yes) OK. Let’s go over how you
responded to the questions. (review questionnaire) As we discussed last week,
negative thoughts and beliefs can be adjusted to thoughts that will support you
getting a good night’s sleep. Can you think of an example of this? How about
another one? As with last week, will you write down any negative thoughts you
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experience during the week. This time will you write down how the thought or
thoughts influence your sleep?”
“Last, but not least, let’s take a look at your diary. (Discuss) Based on our
discussion, sounds like this week you should go to bed at ____ and get up at ____.
Does this sound OK to you? Do you need any supplies? According to my
schedule, we will meet on ____ at _____ next week. If you have any questions,
please don’t hesitate to call.”
Session 5
1. Session Goals
Collect data (sleep diary, blood glucose from
the blood glucose meter and the actigraph results)
Assess treatment gains and barriers
Make adjustments to the participants sleep schedule
Discuss ways to change negative sleep beliefs and attitudes
Discuss relaxation therapies
Participant to practice relaxation techniques using the relaxation CD or
Relaxation Therapy Transcript
Provide relaxation therapy CD and/or relaxation therapy transcript for
participant
2. Session Content (dialog):
“Hello (participant). I’m glad to see you. Will you please tell me how the
past week has been for you? Before I download your blood glucose meter and
actigraph, let’s take a look at your sleep diary.(Assess treatment gains and
barriers.) Based on the results of your diary, let us discuss what adjustments to
make in your sleep schedule. (Make appropriate changes.) Does this sound like
these changes will work for you? While I download your blood glucose meter, will
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you please share with me how your diabetes management has been this week?
Next, while I download your actigraph, is there anything else about your sleep
during the past week that you would like to share?”
“Before we talk about relaxation, did you record any negative sleep beliefs or
attitudes? What did you do to cope with this (these) issue (issues)? (Discuss
concerns)”
“The topic for tonight is relaxation. Before we talk about different forms of
relaxation, it is important to note that relaxation does not mean “going to sleep”.
Relaxation makes it easier to go to sleep. This distinction is important to keep in
mind.”
“The four forms of relaxation therapy are (1)progressive muscle relaxation
(used to reduce skeletal muscle tension; (2)diaphragmatic breathing (used to help
you breathe slower, more deeply and driven from your abdomen rather than your
thorax) (Demonstrate); (3) Autogenic training is designed to increase your blood
flow in your extremities by imaging that your extremities feel warm; and
(4)imagery (using a multisensory approach to imagining a relaxing experience).
Often more than one approach is used in a single activity. Practice is important to
obtain the desired response from these relaxation methods. What method, or
methods, have you tried in the past? How did it work? What approach do you
want to try this week? When will you practice?”
“Before you leave tonight, I’d like you to try a relaxation exercise. Are you
will to do this? I will be reading the exercise for you(Study Manual, p62). You
will also be given a copy of this exercise and also a relaxation CD for you to use
at home this week. I will lower the light as I begin to read the relaxation therapy
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transcript. (read 12 minute session) How was that for you? Keep in mind that this
exercise is more effective the more often that you practice it.”
“Do you have any questions or concerns before you leave? Please keep in
mind that you can contact me anytime. Before you leave, are there any supplies
that you need? I look forward to seeing you next week.”
Session 6
1. Session Goals
Complete Sleep Hygiene Practice Scale and discuss answers
Obtain data (sleep diary, blood sugar results from blood glucose meter,
and actigraph results)
Assess treatment gains and barriers
Make adjustments in the participant’s sleep schedule
Participant to set a sleep hygiene goal
2. Session Content (dialog):
“We are now at session 6 of this program. So far what do you think about
the progress that you have made? (discuss thoughts) During this session we
will talk about what is called sleep hygiene. To introduce this topic, will you
please complete the Sleep Hygiene Practice Scale (Study Manual, p 66)?
you do that I will download you blood glucose meter and your

While
actigraph.”

“Before we review the Sleep Hygiene Practice Scale, let’s look at your
sleep diary. Based on what you have recorded, the recommendation is that you
go to bed at ____. What do you think about that? Did you try to use a
relaxation session? If so, how often and did it help?”
“To begin our discussion on sleep hygiene, let’s go over how you completed
the Sleep Hygiene Practice Scale. (Discuss this tool. Ask what approaches the
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participant has used) Assist the participant to set at least one sleep hygiene
goal. Also review the sleep restriction plan for the coming week. Advise
participant to collect VAS for three days prior to next visit. Also request that
participant check her blood sugar before each meal and also at bedtime

during

the same three days. Discuss any concerns about sleep and/or diabetes.

According

to my calendar you are scheduled to meet on_____ Will this still

work for you?”

Session 7
1. Session Goals
Complete the Glasgow Sleep Effort Scale and discuss
Discuss sleep maintenance
Discuss relapse prevention
Collect data (sleep diary, VAS, Physical Activity Scale, blood glucose from
blood glucose meter, and actigraph results)
Complete initial data collection tools (PSQI, Insomnia Severity Index)
Obtain and record A1C and weight.
Schedule follow up session
2. Session Content (dialog):
“Tonight (today) is our last session, except for your follow up session. Before
we start with tonight’s agenda, do you have anything that you want to discuss?
(Discussion) Per our usual routine, will you please complete the Glasgow Sleep
Effort Scale (Study Manual, p67) while I download your blood glucose meter and
actigraph? (Discuss questionnaire after participant completes the form) Tonight
we need to talk about maintaining the progress that you have made. Preventing
relapse is an important part of recovering from insomnia. What technique that
you have used during this program was the most helpful? (Discuss) Can you see
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any possible barriers to you continue to making progress? Research has shown
that people continue to improve their sleeping behaviors overtime if they continue
to use the techniques that have been learned. Before you complete the
questionnaires that you filled out before you began the study, is there anything
else that you want to discuss? (Discussion) Now, will you please complete the
questionnaires? Before you leave I will give you the supplies that you will need
before the follow up session.”
“Before you leave, here are the supplies you will need to collect data before
the follow up. Please don’t hesitate to call if you have any questions.”

Follow Up Session
1. Session Goals
Collect follow up data (PSQI, Insomnia Severity Index, VAS, Physical
Activity Scale, blood sugar from blood glucose meter and actigraph results,
A1C and weight)
Answer any questions.
If sleep behaviors have not improved, ask the participant to obtain a
polysomnography and share the results.
Thank the participant for participating in the study.
2. Session Content (dialog):
“I’m so glad to see you! How have you been doing? (Discussion) At this
session you need to complete the questionnaires while I will download your blood
glucose machine and your actigraph, In addition I will weigh you and draw your
blood. Before you leave we can discuss any additional issues that you have. “
Provide questionnaires. Download the blood glucose machine and actigraph.
Review the questionnaires for completion before drawing the blood and weighing
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the participant. If the participant has not improved her sleep behaviors, ask her to
obtain a sleep study and share the results. “Now that we have collected this
information, what else do you want to discuss? (Discussion) Thank you so much
for participating in this study. You have my phone number to call for any future
questionnaires. When the presentation of this study is scheduled, I will notify you
if you want to attend.”
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Screening Tools
Screening Tool
ID___________ DATE________
Inclusion Criteria

____ female gender
____ type 2 diabetes for a minimum of one year
____ 60-70 years of age
____ fragmented sleep
____ medically stable
____ able to complete data collection tools

Exclusion Criteria

____ Medical conditions: Diagnosed sleeping disorders, major depressive disorder,
psychiatric disorders
____ Medications: sleeping medications, steroids
____ Suicidal thoughts
____ Cognitive Impairment - MMS results

106

Demographic Questionnaire
ID__________ DATE_________
Sex: Female____
Age: _______years
Educational level
Some high school ____
High School graduate ____
Some College ____
College Graduate ____
Master’s degree ______
PhD ______
Marital Status
Single ____
Divorced ____
Married ____
Widowed ____
Insurance
Medicare ____
Private ____
Medicaid ____
None ____
Employment
Full time ____
Part time ____ hours _____
Retired ______
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Medical History Checklist
Medical History Information Form
Current weight:
Current height:
Weight 5 years ago:
Blood Pressure

_______
_______
_______
_______

Medication

ID: ________________________
Date: ________________________
BMI: _________________________
A1C: ________________________
Dose

Schedule

Reason taking it

Put checkmark in the box:


















Head injury
 Colitis
 Pneumonia
Hemorrhage
 Constipation
 Tuberculosis
Meningitis
 Gastric Ulcer Disease
 Cancer
Migraine
 Pancreatitis
 Diabetes
Multiple Sclerosis
 Gastric bleeding
 Thyroid Problems
Parkinson’s
 Heartburn
 Obesity
Seizures
 Esophageal Reflux
 Arthritis
Stroke
 Cystitis
 Fibromyalgia
Shingles
 Kidney Stones
 HIV disease
Chest pain
 Menopause
 Psoriasis
Irregular Heart Rhythm
 Ovarian Cysts
 Hives or rashes
Congestive Heart Failure
 Pelvic Inflammatory Disease
 Dental problem
Heart Attack
 Kidney failure
 Grinding teeth
Vision problem
 Blood disorders
 Sleep Apnea
Blood Clots
 Chronic Pain
 Restless Legs
Asthma
 Hepatitis
 Liver Disease
Other: ______________________________________________________________________
List Surgeries with dates: _______________________________________________________
____________________________________________________________________________
Question: During the past year, have you had thoughts that you would be better off dead, or hurting yourself in some way?
Not at all ___ Several days___ More than half of days____ Nearly every day____
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ID______ DATE_______
Outline Plan for a Sleep History Assessment Comprising Content Areas and
Suggested Interview Questions
Content Area

Prompt question

Supplementary questions

Presentation of the sleep complaint
Pattern

Can you describe the pattern of your
sleep on a typical night?

Time to fall asleep?
Number and duration of wakenings?
Time spent asleep?
Nights per week like this?

Quality

How do you feel about the quality of
your sleep?

Refreshing?
Enjoyable?
Restless?

Daytime effects

How does your night’s sleep affect
your day?

Tired?
Sleepy?
Poor concentration?
Irritable?
Particular times of day?

Development of the sleep complaint

Do you remember how this spell of
poor sleep started?

Events and circumstances?
Dates and times?
Variation since then?
Exacerbating factors?
Alleviating factors?
Degree of impact/intrusiveness?

Lifetime history of sleep complaints

Did you used to be a good sleeper?

Sleep in childhood?
Sleep in adulthood?
Nature of past episodes?
Dates and times?
Resolution of past episodes?

General health status and medical
history

Have you generally kept in good
health?

Illnesses?
Chronic problem?
Dates and times?
Recent changes in health?

Psychopathology and history of
psychological functioning

Are you the kind of person who
usually copes well?

Psychological problems?
Anxiety or depression?
Dates and times?
Resourceful person?
Personality type?

Issues of differential diagnosis

Are you a heavy snorer?

Interrupted breathing in sleep?
Excessively sleepy in the day?

Sleep-related breathing disorder
(SBD)

Excessively sleepy in the day?
Trouble sitting still without moving
the extremities?

Periodic limb movements in sleep
(PLMS) and restless legs syndrome
(RLS)

Do your legs sometimes twitch or
can’t keep still?

Circadian rhythm sleep disorders

Do you feel you want to sleep at the
wrong time?

Behavioral description?
Time during night?

Do you sometimes act a bit strangely
during your sleep?

Times and places?
Collapses triggered by emotion?

Too early?
Too late?

Parasomnias
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Content Area

Prompt question

Narcolepsy

Do you sometimes just fall asleep
without warning?

Supplementary questions
Poor sleep at night?

ID ____________________
Date__________________
MINI-MENTAL STATE
Maximum
Score

Score

5

(

)

ORIENTATION
What is the (year) (season) (date) (day) (month)?

5

(

)

Where are we: (state) (country) (town) (hospital) (floor).

(

)

3

REGISTRATION
Name 3 objects: 1 second to say each. Then ask the patient all 3 after
you have said them. Give 1 point for each correct answer. Then repeat
them until he learns all 3. Count trials and record.
Trials
MINI-MENTAL STATE
ATTENTION AND CALCULATION

5

(

)

Serial 7’s 1 point for each correct. Stop after 5 answers. Alternatively
spell “world” backwards.

3

(

)

Ask for the 3 objects repeated above. Give 1 point for each correct.

9

(

)

Name a pencil, and watch (2 points)

Repeat the following “No ifs, and or buts.” (1 point)
Follow a 3-stage command:
“Take a paper in your right hand, fold it in half, and put it on the floor”
(3 points)
Read and obey the following:
CLOSE YOUR EYES (1 point)
Write a sentence (1 point)
Copy design (1 point)
Total score
ASSESS level of consciousness along a continuum
Alert

Drowsy

Stupor

Coma
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Orientation Tools

111

112

113

114

115

116

Sleep
Diary

117
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Pittsburgh Sleep Quality Index (PSQI)
ID: _____________________________ Date:________________ Age __________
Instructions:
The following questions relate to your usual sleep habits during the past month only.
Your answers should indicate the most accurate reply for the majority of days and nights
in the past month.
Please answer all questions.
1. During the past month, when have you usually gone to bed at night?
USUAL BED TIME _____________________________
2. During the past month, how long (in minutes) has it usually take you to fall asleep each
night?
NUMBER OF MINUTES _________________________
3. During the past month, when you have you usually gotten up in the morning?
USUAL GETTING UP TIME ______________________
4. During the past month, how many hours of actual sleep did you get at night? (This may be
different than the number of hours you spend in bed.)
HOURS OF SLEEP PER NIGHT___________________
For each of the remaining questions, check the one best response. Please answer all questions.
5. During the past month, how often have you had trouble sleeping because you…
a) Cannot get to sleep within 30 minutes
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
b) Wake up in the middle of the night or early morning
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
c) Have to get up to use the bathroom
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
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d) Cannot breathe comfortably
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
e) Cough or snore loudly
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
f) Feel too cold
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
g) Feel too hot
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
h) Had bad dream
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
i) Have pain
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week____
j) Other reason(s), please describe
___________________________________________________________________________
_______________________________________________________________________
How often during the past month have you had trouble sleeping because of this?
Not during
Less than
Once or Three or more
past month____ once a week____ twice a week____ times a week___
6. During the past month, how would you rate your sleep quality overall?
Very good ____
Fairly good ____
Fairly bad ____
Very bad ____
7. During the past month, how often have you taken medicine (prescribed or “over the
counter”) to help you sleep?
Not during
Less than
Once or
Three or more
past month____
once a week____ twice a week____ times a week____
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The Insomnia Severity Index
ID: _____________________________ Date:_______________________
8. Please rate the current (i.e., last 2 weeks) severity of your insomnia problem(s).

a. Difficulty falling asleep:
b. Difficulty staying asleep:
c. Problem waking up too
early:

None
0
1
0
1
0
1

Mild

Moderate
2
3
2
3
2
3

Severe
4
4
4

Very

9. How satisfied/dissatisfied are you with your current sleep pattern?
Very satisfied Satisfied
0
1

Neutral
2

Dissatisfied Very Dissatisfied
3
4

10. To what extent do you consider your sleep problem to interfere with your daily functioning
(e.g. daytime fatigue, ability to function at work/daily chores, concentration, memory,
mood, etc.).
Not at all
Very much
interfering
A little
Somewhat Much interfering
0
1
2
3
4
11. How noticeable to others do you think your sleeping problem is in terms of impairing the
quality of your life?
Not at all
Very much
noticeable
A little
Somewhat Much noticeable
0
1
2
3
4
12. How worried/distressed are you about your current sleep problem?
Not all all
Very much
worried
A little
Somewhat Much
worried
0
1
2
3
4
Guidelines for Scoring/Interpretation
Add scores for all seven items (1a + 1b + 1c + 2 + 3 + 4 + 5) =
Total score ranges from 0-28; if total score falls between:
0-7 = No clinically significant insomnia
8-14 = Subthreshold insomnia
15-21 = Clinical insomnia (moderate severity)
22-28 = Clinical insomnia (severe)
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Teaching Tools
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Class Outline
Session

Content

Participant Activities

Session 1

Review CBTI, sleep diaries, blood
glucose meter, wrist actigraphy.
Introduce sleep restriction.

Session 2

Sleep Restriction
Stimulus Control Therapy

Session 3

Introduce Cognitive Therapy

Session 4

Cognitive Therapy
Introduction to other therapies

Session 5

Relaxation Therapies

Session 6:

Sleep Hygiene

1. Review Class Outline
2. Complete Motivation for
Change and review
3. Complete Sleep Behavior SelfRating Scale and review
4. Discuss sleep restriction
5. Review Sleep Diary results and
set sleep goals
6.Download BG meter & actigraph.
1. Complete Sleep Environment
Checklist and review
2. Complete Caffeine Knowledge
Quiz and review
3. Review Sleep Diary Results and
set sleep goals.
4. Download BG meter & actigraph
1. Complete The Pre-Sleep Arousal
Scale and review
2. Discuss overview of Cognitive
Therapy
3. Review Sleep Diary results and
set sleep goals
4. Download BG meter & actigraph
1.Complete Dysfunctional Beliefs
and Attitudes about Sleep Scale and
review.
2. Review Sleep Diary results and
set sleep goals.
3. Download BG meter & actigraph
1. Discuss ways to change negative
sleep beliefs and attitudes.
2. Discuss Relaxation Therapies
3. Review Sleep Diary results and
set sleep goals.
4. Provide Relaxation CD &
Relaxation Therapy Transcript
5. Download BG meter & actigraph
1. Complete Sleep Hygience
Practice Scale and discuss
2. Set sleep hygiene goal
3. Review Sleep Diary results and
set sleep goals.

125

Session 7:

Sleep Maintenance and
Relapse Prevention
Data collection

4. Download BG meter & actigraph
5. Provide shower gel and body
lotion.
1. Complete The Glasgow Sleep
Effort Scale and Discuss.
2. Review Sleep Diary results and
discuss future goals
3. Discuss sleep maintenance and
Relapse Prevention
4. Download BG meter & actigraph
5. Complete data collection tools.
Pittsburgh Sleep Quality Index
Insomnia Severity Index
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Sleep Restriction Guidelines

In the case of positive clinical gains (Sleep Efficiency (SE) > 90 %) –
upwardly titrate total sleep opportunity.
In the case of no or marginal gains (SE between 85 and 90 %),
maintain schedule.
In the case of negative gains (SE < 85%), downwardly titrate total
sleep opportunity.
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Motivation for Change Index
MFCI
(Motivation For Change Index)

ID: _____________________________ Date:_______________________
13. Because of my insomnia I can’t (Please list)
_____________________________ ________________________________
_____________________________ ________________________________
_____________________________ ________________________________
_____________________________ ________________________________
_____________________________ ________________________________
14. If there were a treatment we could use that would, as of tomorrow, fix you insomnia—in
what way(s) would your life be better?
_____________________________ ________________________________
_____________________________ ________________________________
_____________________________ ________________________________
_____________________________ ________________________________
_____________________________ ________________________________
15. If there were a treatment we could use that would fix your insomnia how many hours per
week would you be willing to invest in the process?
____ 1 hour____ 2 hour____ 4 hour____ 8 hour____ 10 hour
16. If there were a treatment we could use that would fix your insomnia BUT it would take time,
how long would you be willing to wait?
____ 1 week

____ 2 weeks

____ 4 weeks

____ 8 weeks

____ 10 weeks

17. If there were a treatment we could use that would fix your insomnia BUT to get better it
would mean that you’d get worse before you get better, how much worse would you be
willing to get?
____ 10% ____ 20% ____ 40% ____ 80% ____ 100%
18. To make a difference in your life, how much improvement would represent a real
accomplishment?
____ 10% ____ 20% ____ 40% ____ 80% ____ 100%
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Sleep Behavior Self-Rating Scale
Instructions for patients

ID______ DATE_____

This rating scale helps us to understand what your behavior patterns around
bedtime is like. It is fairly self-explanatory. Please take a few minutes to fill
it in as accurately as you can. Please indicate how often you do the following
things in your bed before falling asleep or while in your bedroom. Complete
the form by considering what you would do in an average week.
Behavior

Never

Rarely

Sometimes Often

Read a book
or magazine

Watch TV
Listen to the
radio
Have a
conversation
with
someone
Speak on
the
telephone
Eat or drink
Smoke
Please also answer the following
I take naps
during the
day or
evening
I fell sleepy
when I go to
bed
I switch the
light off as
soon as I get
into bed
I spend a lot

questions:

Very
Often
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of time
lying awake
in bed at
night
If I can’t get
to sleep
within
approx. 20
minutes I
get out of
bed and
move to
another
room until I
feel sleepy
again
I set myself
a regular
rising time
each
morning
If I have a
bad night’s
sleep I still
get up at my
usual time
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Sleep Environment Checklist
1.

True
2.

False

Not Applicable

False

Not Applicable

False

Not Applicable

False

Not Applicable

On three or more nights per week, I engage in two or more of the following behaviors in the
bedroom: watch TV, read, plan, worry, work, clean, or eat.
True

9.

Not Applicable

My home is a safe place. My partner and/or pet and/or the locks and alarm system and/or concern
and support of my neighbors provide me a level of comfort such that I rarely if ever worry about
being safe at night.
True

8.

False

House noise from the radiators, floor boards, etc. is so minimal that I am rarely aware of such sounds.
True

7.

Not Applicable

During the night, my bedroom is insulated so well that I rarely if ever hear outside noise from the
road, neighbors, etc.
True

6.

False

I have spent real time and money making sure that my mattress and pillow are perfect for me.
True

5.

Not Applicable

The blinds and curtains in the bedroom are so effective that at sunrise the room is so dark its hard to
tell that the sun came up.
True

4.

False

I keep the temperature in the bedroom so cold that I have 2 or more blankets on the bed to stay
warm at night.
True

3.

ID______ DATE_____

SLEEP ENVIRONMENT QUESTIONNAIRE
I use an alarm clock five or more days a week.

False

Not Applicable

My pets rarely, if ever, keep me from falling asleep or wake me up during the night.
True

False

Not Applicable

10. My bed partner’s sleep schedule or habits while in bed (reading, moving about, stealing the covers,
snoring, etc.) rarely, if ever, disturb my sleep.
True

False

Not Applicable
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11. My child’s/children’s sleep schedule or habits while in bed or during the night rarely if ever disturb
my sleep.
True

False

Not Applicable
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ID______ DATE_____

Caffeine Knowledge Quiz
For each item on the following list, indicate whether you believe it contains caffeine or
another stimulant by placing a Y (yes) or an N (no) in the space provided. If you are not
sure, make your best guess. If you have never heard of an item please place an X in the
space._________

____7-Up soft drink
____regular tea
____Dristan cold remedy
____aspirin
____Dr. Pepper soft drink
____Midol menstrual relief

____lemonade
____root beer
____chocolate cake
____regular coffee
____Excedrin
____Sudafed decongestant

____Mountain Dew
____cola soft drinks
____Dexatrim diet pills
____Tylenol
____Aqua Ban diuretic
____Sprite soft drink
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The Pre-Sleep Arousal Scale

ID_____ DATE____

Instructions to patient
This scale is fairly self-explanatory. We are interested to find out about how
you are feeling in your mind and in your body before you fall asleep. Please
describe how intensely you experience each of the symptoms mentioned
below as you attempt to fall asleep, by circling the appropriate number.
Further instructions to clinician
Two separate scores can be obtained for the PSAS. The sub-scale score for
cognitive arousal comprises the total of items 1 to 8, and the sub-scale score
for somatic arousal comprises the total of items 9 to 16.
Not at all

Slightly Moderately A lot

Extremely

_____________________________________________________________
1. Worry about
falling asleep
1
2
3
4
5
2. Review or ponder
the events of the day

1

2

3

4

5

3. Depressing or
anxious thoughts

1

2

3

4

5

4. Worry about problems
other than sleep

1

2

3

4

5

5. Being mentally alert,
active

1

2

3

4

5

6. Can’t shut off your
thoughts

1

2

3

4

5

7. Thoughts keep running
through your head

1

2

3

4

5

12. Being distracted by
sounds, noise in the
environment

1

2

3

4

5

134

Not at all

Slightly Moderately A lot

Extremely

9. Heart racing, pounding
or beating irregularly

1

2

3

4

5

10. A jittery, nervous feeling
in your body

1

2

3

4

5

13. Shortness of breath
or labored breathing

1

2

3

4

5

14. A tight, tense feeling
in your muscles

1

2

3

4

5

15. Cold feeling in your
hands, feet or your
body in general

1

2

3

4

5

16. Have stomach upset
(knot or nervous feeling
in stomach, heartburn,
nausea, gas, etc.)

1

2

3

4

5

17. Perspiration in palms
of your hands or other
parts of your body

1

2

3

4

5

18. Dry feeling in mouth
or throat

1

2

3

4

5
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Dsyfunctional Beliefs and Attitudes about
Sleep Scale
ID: _____________________________ Date:_______________________
Instructions
Several statements reflecting people’s beliefs and attitudes about sleep are listed below.
Please indicate to what extent you personally agree or disagree with each statement.
There is no right or wrong answer. For each statement, circle the number that
corresponds to your own personal belief. Please respond to all items even though some
may not apply directly to your own situation.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

19. I need 8 hours of sleep to feel refreshed and function well during the day.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

20. When I don’t get proper amount of sleep on a given night, I need to catch up on the next
day by napping or on the next night by sleeping longer.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

21. Because I am getting older, I need less sleep.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

22. I am worried that if I go for 1 or 2 nights without sleep, I may have a “nervous breakdown.”
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

23. I am concerned that chronic insomnia may have serious consequences on my physical
health.
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Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

24. By spending more time in bed, I usually get more sleep and feel better the next day.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

25. When I have trouble falling asleep or getting back to sleep after nighttime awakening, I
should stay in bed and try harder.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

26. I am worried that I may lose control over my abilities to sleep.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

27. Because I am getting older, I should go to bed earlier in the evening.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

28. After a poor night’s sleep, I know that it will interfere with my daily activities on the next
day.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

29. In order to be alert and function well during the day, I believe I would be better off taking a
sleeping pill rather than having a poor night’s sleep.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10
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30. When I feel irritable, depressed, or anxious during the day, it is mostly because I did not
sleep well the night before.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

31. Because my bed partner falls asleep as soon as his/her head hits the pillow and stays asleep
through the night, I should be able to do so too.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

32. I feel that insomnia is basically the result of aging and there isn’t much that can be done
about this problem.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

33. I am sometimes afraid of dying in my sleep.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

34. When I have a good night’s sleep, I know that I will have to pay for it on the following night.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

35. When I sleep poorly on one night, I know it will disturb my sleep schedule for the whole
week.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

138

36. Without an adequate night’s sleep, I can hardly function the next day.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

37. I can’t ever predict whether I’ll have a good or poor night’s sleep.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

38. I have little ability to manage the negative consequences of disturbed sleep.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

39. When I feel tired, have no energy, or just seem not to function well during the day, it is
generally because I did not sleep well the night before.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

40. I get overwhelmed by my thoughts at night and often feel I have no control over this racing
mind.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

41. I feel I can still lead a satisfactory life despite sleep difficulties.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

42. I believe insomnia is essentially the result of a chemical imbalance.
Strongly
disagree

Strongly
________________________________________________agree___
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0

1

2

3

4

5

6

7

8

9

10

43. I feel insomnia is running my ability to enjoy life and prevents me from doing what I want.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

44. A “nightcap” before bedtime is a good solution to sleep problem.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

45. Medication is probably the only solution to sleeplessness.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

46. My sleep is getting worse all the time and I don’t believe anyone can help.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

47. It usually shows in my physical appearance when I haven’t slept well.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10

48. I avoid or cancel obligations (social, family) after a poor night’s sleep.
Strongly
disagree
0 1

Strongly
________________________________________________agree___
2 3 4 5 6 7 8 9 10
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Scoring and interpretation guidelines
The total DBAS score is obtained by adding the score of each item (reverse score for item 23)
and dividing by the total number of items. There are no norms available for this scale but a
higher score indicates that your patient endorses more intense and more frequent dysfunctional
beliefs and attitudes about sleep.
An abbreviated 16-item version is currently under validation.
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Relaxation Therapy Session Transcript
Version 1

The exercises on this tape are designed to help you relax. Relaxation is a
skill, which you can learn. It is just like any other skill, so don’t be surprised
if you find it takes practice because this is how we learn skills. So do
practice. Practice a couple of times a day, especially as you start to learn. Of
course, you will want to use the relaxation when you go to bed, to help you
relax and go to sleep, but you will find it most useful if you have already
learned what to do.
It is best to practice at a time when you know you won’t be disturbed.
The tape will last between ten and fifteen minutes so you will need at least
that length of time set aside. When you do your relaxation exercises in your
bed, you will be able to listen to the tape there too. But after a while you will
have learned what to do and you will be able to just follow the exercises in
your own mind.
The exercises themselves begin now,
Settle yourself down. Lie down with your hands and arms by your sides;
have your eyes closed. That’s good.
We will start by just thinking about your breathing. Your breathing can
help you relax; the more deep and relaxed it is the better you will feel and
the more in control you will feel. So begin by taking some slow regular
breaths. Do that now. Breathe in fully, fill up your lungs fully; breathe in,
hold your breath for a few seconds now, and let go, breathe out… Do that
again, another deep breath, filling in your lungs fully when you breathe in,
hold it… and relax, breathe out. Continue that in your own time, noticing
that each time you breathe in the muscles in your chest tighten up, and as
you breathe out there is a sense of letting go. You can think the word ‘relax’,
each time you breathe out. This will remind you that breathing out helps you
to relax. It will also help you to use this word to tell yourself to relax
whenever you need to. You will find that your body will begin to respond.
Breathing slowly, comfortably, regularly, and deeply; thinking the word
‘relax’ every time you breathe out; enjoying just lying still and having these
moments to relax, concentrating on the exercises.
Now, I’d like you to turn your attention to your arms and hands. At the
moment just lie them at your sides. I’d like you to create some tension in
your hands and arms by pressing your fingers into the palms of your hands
and making fists. Do that with both hands now. Fell the tension in your
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hands, feel the tension in your fingers and in your wrists, feel the tension in
your forearms. Notice what it is like. Keep it going…and now relax. Let
those hands flop. Let then do whatever they want to do; just let them relax.
Breathing slowly and deeply, you will find that your fingers will just
straighten out and flop, and your hands and arms will feel more relaxed.
Allow them to sink into the couch or into the bed, just allow your arms to be
heavy. Breathing slowly and deeply, thinking the word ‘relax’ each time you
breathe out, and finding that your hands and arms just relax more and more
and more. Your arms and your hands are so heavy and rested. It’s almost as
if you couldn’t be bothered moving them. Just because you have let go of the
energy and tension that was in the muscles there. Breathing slowly and
deeply, both your hands, both your arms, are heavy and rested. Let go of the
energy and tension that was in the muscles there, breathing slowly and
deeply. Both your hands, both your arms, are heavy and rested and relaxed.
I’d like you to turn attention now to your neck and shoulders. Again
we’re going to get your neck an shoulders into a state of relaxation following
some tension. We’re going to introduce. I’d like you to do that by pulling
your shoulders up towards your ears. Now, do that; pull your shoulders up
towards your ears. Feel the tension across the back of your neck, across the
top of your back and in your shoulders. Feel the tension, keep it going not so
much that it’s sore, but keep it constant. Feel it, and now let it go…relax; go
back to breathing slowly and deeply. Let that tension drain away, let it go.
Breathe deeply, and as you do so, notice that the tension, almost like a
stream, drains away from your neck, across you shoulders, down the upper
part of your arms, down the lower part of your arms and out through you
fingertips. Draining out and leaving a sense of warmth and relaxation deep
in your muscles. Breathing slowly and deeply and allowing that to take
place. Just let the tension go. If it doesn’t seen to go don’t force it, it will go
itself. Be confident about that. Just breathe slowly and deeply and allow
yourself to be relaxed; remembering to think the word ‘relax’, each time you
breathe out. Using the word ‘relax’ to focus on the sense of relaxation that
you get, using the word ‘relax’ to remind you of the success your are having
in relaxing your body.
I’d like you to concentrate now on your face, and on your jaw, and on
your forehead. I’d like you to create some tension in these parts of your body
by doing two things together at the same time. These things are to screw up
your eyes really tightly and bite your teeth together. Do these things together
now. Bite your teeth together; feel the tension in your jaw. Screw up your
eyes; feel the tension all around your eyes, in your forehead, in your cheeks,
throughout your face, wherever there is tension. Now keep it going…and
relax; breathing in through your nose and out through your mouth, slowly
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and deeply. Notice how your forehead smoothes out and then your eyelids
and your cheeks. Allow your jaw to hang slightly open. Allow your whole
head to feel heavy and to sink into the pillow; breathing slowly and deeply.
Allow there to be a spread of relaxation across the surface of your face and
into all those muscles in your face. Allow your eyelids to feel heavy and
comfortable, your jaw and your whole head; breathing slowly and deeply,
enjoying the relaxation which you feel in your whole body. Relax each time
you breathe out. Relax just that little bit more each time you breathe out.
Concentrating now on your legs and feet, I want you to create some
tension here by doing two things at the same time; and these things are to
press the backs of your legs downwards and to pull your toes back towards
your head. Do these things together now. Create the tension in your legs,
press the backs of your legs downwards and pull your toes back towards
your head. Feel the tension in your feet, in your toes, in your ankles, in the
muscles in your legs. Feel what it is like. Don’t overdo it; just notice what it
is like…and relax. Breathing slowly and deeply once more; just allow your
feet to flop any old way. Allow the muscles to give up their energy, give up
their tension. Let it go, breathing slowly and deeply. Notice how your feet
just want to flop to the side. Notice how your legs feel heavy as if you
couldn’t be bothered moving them. They are heavy and comfortable and
rested and relaxed. Just that little bit more relaxed each time you breathe out.
Be thinking about your whole body now; supported by the bed, sinking
into it, but supported by it. You’ve let go the tension throughout your body.
Your body feels rested, comfortable. Enjoy each deep breath you take. Just
use these few moments now to think about any part of your body that that
doesn’t feel quite so rested and allow the tension to go. It will go. Breathe
slowly and deeply; thinking the word ‘relax’ each time you breathe out. Just
let any remaining tension drain away; from your hands, your arms, your
neck and your back. They are heavy and rested, comfortable and relaxed,
from your face and your eyes, from your forehead; letting the muscles give
up their energy. Like a steam of relaxation flowing over your whole body.
Let your legs and feet feel relaxed; sinking into the bed. Breathe slowly and
deeply.
In a few moments, this tape will finish; but you can continue to relax.
You may wish to repeat some of the exercises yourself and that is fine. You
may wish to enjoy just continuing as you are. You may with to think on a
visualization scene or build pictures in your mind that will help you to relax
further. It’s up to you, but continue to relax. End of tape.
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Relaxation CD
Version 2
Sleep Hygiene Practice Scale
For each of the following behaviors, state the number of days per week (0-7) that you
engage in that activity or have that experience. Base your answers on what you would
consider an average week for yourself. Indicate the number of days or nights in an
average week you:

Days per
week
1.
2.
3.
4.
5.
6.

Take a nap.
Go to bed hungry.
Go to bed thirsty.
Smoke more than one packet of 144igarettes per day.
Use sleeping medications (prescribed or over the counter).
Drink beverages containing caffeine (e.g. coffee, tea, cola) within 4
hours of bedtime.
7. Drink more than 3 ounces of alcohol (e.g. 3 mixed drinks, 2 beers or 3
glasses of wine within two hours of bedtime.
8. Take medications/drugs with caffeine within 4 hours of bedtime.
9. Worry as you prepare for bed about your inability to sleep.
10. Worry during the day about your inability to sleep at night.
11. Use alcohol to facilitate sleep.
12. Exercise strenuously within 2 hours of bedtime.
13. Have your sleep disturbed by light.
14. Have your sleep disturbed by noise.
15. Have your sleep disturbed by your bedpartner (put N/A if no partner).
16. Sleep approximately the same length each night.
17. Set aside time to relax before bedtime.
18. Exercise in the afternoon or early evening.
19. Have a comfortable night-time temperature in your bed/bedroom.
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The Glasgow Sleep Effort Scale
The following seven statements relate to your night-time sleep pattern in the past week.
Please indicate by circling one response how true each statement if for you.
1. I put too much effort into sleeping at night when it should come naturally
Very much

To some extent

Not at all

2. I feel I should be able to control my sleep at night
Very much

To some extent

Not at all

3. I put off going to bed at night for fear of not being able to sleep
Very much

To some extent

Not at all

4. I worry about not sleeping if I am in bed at night and cannot sleep
Very much

To some extent

Not at all

5. I am no good at sleeping at nights
Very much

To some extent

Not at all

6. I get anxious about sleeping before I go to bed at night
Very much

To some extent

Not at all

7. I worry about the long term consequences of not sleep at night
Very much

To some extent

Not at all
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Diabetes is one of the most serious health challenges in the United States,

affecting nearly 21 million Americans. The goal of diabetes management is to maintain
the blood glucose close to normal to prevent diabetic complications and therefore
extending life expectancy and improving quality of life. Research now indicates a
relationship of the quantity and quality of sleep to glycemic control in type 2 diabetics.
No research on the impact of insomnia on diabetes prevention and/or management was
found in the literature. The purpose of this 11-week intervention study was to examine
the effects of participation in Cognitive Behavioral Therapy for Insomnia (CBTI) on the
sleep quality, quantity and insomnia severity of aging women (50-74 years) with type 2
diabetes for at least one year and insomnia for a minimum of six months. The secondary
purpose was to determine the relationship among changes in sleep quality and quantity,
metabolic control and diabetes self-management behaviors. Nine participants aged 56 to
69 completed the orientation, seven week intervention and 3-week follow-up. The global
sleep quality scores, measured by the Pittsburgh Sleep Quality Index, demonstrated an
improvement in sleep quality. Insomnia severity, as measured by the Insomnia Severity
Index, was found to decrease insomnia severity from the moderate level insomnia group
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to the sub threshold insomnia group. Although sleep quantity, as measured by the
Actiwatch 2, decreased during the intervention as a result of sleep restriction the amount
of sleep had begun to increase at posttest. Using the Physical Activity Scale, the mean
number of minutes in seven of the eight measures increased from pretest to 3-week
follow-up. Using the Analog Scale for Appetite, appetite for sweets was found to
significantly decrease as the sleep quality improved. Eight of the nine participants were
found to have lower A1C levels at the 3-week follow-up. In summary, CBTI was found
to improve self-reported sleep quality. As a result, physical activity increased and
appetite decreased, especially for sweet foods. Hemoglobin A1C levels decreased in eight
of the nine participants. Improved insomnia may improve metabolic control and improve
diabetes self-management behaviors. Additional research is needed.
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